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ABSTRACT 
DETRIMENTAL EFFECTS OF INACTIVITY ON INSULIN ACTION 
 
MAY 2009 
 
BROOKE R. STEPHENS, B.S. CREIGHTON UNIVERSITY 
 
M.S., BALL STATE UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Barry Braun 
 
 Inactivity reduces insulin action. Energy surplus causes similar reductions to 
insulin action. Unless energy intake is reduced to match low energy expenditure during 
inactivity, a concurrent energy surplus may account for the lower insulin action. This 
study evaluated the effect of inactivity (sitting) with and without energy surplus on 
insulin action. Fourteen young (26.1 ± 4.5 years (M ± SD)), lean (23.7 ± 7.1% fat), fit 
(VO2peak = 49.1 ± 3.3 ml•kg-1•min-1)  men (n=7) and women (n=7) completed each of 3, 
24-hour conditions: an active condition (i.e. high energy expenditure with energy intake  
matched to expenditure) = ACTIV; 2) reduced energy expenditure (inactivity) with no 
reduction in energy intake (i.e. energy surplus) = INACTIV; 3) inactivity with energy 
intake reduced to match low energy expenditure = INACTIV LO-CAL. Insulin action 
was measured during a glucose infusion the following morning. Data were analyzed 
using linear mixed-effects models with planned contrasts.  Compared to ACTIV, insulin 
action, defined as whole-body rate of glucose disappearance (Rd) scaled to steady-state 
plasma insulin, was reduced 39% in INACTIV (p < 0.001) and by 18% in INACTIV LO-
CAL (p = 0.07). Insulin action was also higher in INACTIV LO-CAL compared to 
INACTIV (p =0.04). These results suggest that 1 day of sitting elicits large reductions in 
 vii 
insulin action. Energy surplus accounts for half of the decline in insulin action, 
suggesting other factors are involved in the metabolic response to inactivity.  
 viii 
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CHAPTER 1 
INTRODUCTION 
 
It is well-established that structured exercise confers benefits to metabolic health 
and reduces risk for disease (29, 74, 95, 96, 101).  Limited epidemiological data suggest 
that low-intensity activities of daily living, such as standing, ambulation, etc. (i.e. activity 
not defined as exercise), are also beneficial to metabolic health (59, 70). However, the 
relative importance of non-exercise physical activity, versus structured exercise, on 
health is less understood.  Physical inactivity (i.e. considerable reductions in ambulation 
and standing), imposed by hindlimb suspension in rodents or bed rest in humans, clearly 
reduces insulin action (32, 90, 100, 119, 131, 133, 137) and impairs lipid metabolism (10, 
14, 100).  
Although a recent study examined the metabolic response to large reductions in 
daily walking (e.g. from10,000 steps/d to < 1500 steps/d) (114), no published studies 
have focused on the direct effects of more typical sedentary behaviors involving sitting 
(e.g. watching television, working on a computer, etc.). Understanding the metabolic 
impact of prolonged sitting has real-world relevance (54) since many people spend 
considerable  amounts of time engaged in sedentary behaviors involving sitting (17, 97). 
The underlying mechanism(s) for the impaired insulin action and lipid 
metabolism in response to physical inactivity are not well-characterized.  A previously 
unexplored mechanism (i.e. energy imbalance) may be involved in the inactivity-induced 
decline in metabolic health.  Less standing and ambulation reduces energy expenditure 
and leads to energy surplus unless energy intake is reduced to match the low expenditure.  
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Energy surplus independently reduces insulin action (4, 113) and impairs lipid 
metabolism (103).  Therefore, the effects attributed to inactivity may actually be 
mediated by a concurrent energy surplus.  However, no studies have determined the 
discrete effect of inactivity itself from the confounding impact of energy surplus by 
lowering energy intake to match the lower energy expenditure.  Therefore, this study was 
designed to: 1) evaluate the metabolic impact of inactivity (sitting) and 2) to determine 
whether inactivity-induced declines in insulin action and lipid metabolism are attributable 
to energy surplus.  
1.1 Specific Aims and hypotheses 
To test the specific aims of this study, subjects completed 3 different conditions: 
1) an active condition (i.e. high energy expenditure with energy intake matched to 
expenditure) = ACTIV; 2) reduced energy expenditure (inactivity) without a concomitant 
reduction in energy intake (energy intake > expenditure, i.e. energy surplus) = INACTIV; 
3) inactivity with energy intake reduced to match the low expenditure = INACTIV LO-
CAL.  Specific aims and hypotheses of the study are presented below. 
Aim 1: Determine the effect of 24 hours of inactivity, with no change to energy 
intake, on insulin-mediated glucose uptake (insulin action).  We expected that inactivity 
would significantly reduce insulin-mediated glucose disposal (i.e. insulin action) relative 
to the active condition (i.e. INACTIV < ACTIV). 
Aim 2:  Determine the effect of 24 hours of inactivity, without the potential 
confounding effect of energy surplus, on insulin action.  We expected that reducing 
energy intake to match low expenditure would attenuate, but not completely prevent, the 
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inactivity-induced decline in insulin action (i.e. INACTIV < INACTIV LO-CAL < 
ACTIV). 
Aim 3: To determine the effect of inactivity on lipid metabolism. We expected 
that inactivity, with no change in energy intake, would impair: fasting lipid oxidation, 
fasting free fatty acid and triacylglycerol concentrations, and insulin-mediated 
suppression of lipolysis.  However, we expected that reducing energy intake to match low 
expenditure would attenuate impairments to lipid metabolism relative to the active 
condition (i.e. INACTIV < INACTIV LO-CAL < ACTIV).  
1.2 Significance 
The aims of this study are to understand the metabolic response to 24 hours of 
sitting and to determine whether the deleterious effects of inactivity on that response are 
at least partially attributable to energy surplus.  Results from this study will provide 
insights into factors that reduce insulin action and impair lipid metabolism following 
inactivity.  Knowledge gained from this study is critically important to tailor appropriate 
public health recommendations to oppose the rapid and potentially frequent declines in 
metabolic health that result from sitting too much. 
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CHAPTER 2  
REVIEW OF LITERATURE 
2.1 Associations of physical activity and health 
It is well-established that exercise improves cardiometabolic health and reduces 
risk of disease (29, 74, 95, 96, 101). Epidemiological investigations have repeatedly 
demonstrated a negative association between physical activity level and/or fitness and all-
cause mortality (13), cardiovascular mortality (13, 38, 104, 105), and incidence of type 2 
diabetes (13, 38, 64, 95, 104, 105) independent of age or obesity status.  Data from cross-
sectional observations have shown habitually active individuals are more insulin sensitive 
(30, 102, 126), have elevated HDL cholesterol (66, 141, 151, 152), reduced LDL 
cholesterol and triacylglycerol levels (141, 151, 152), have a greater capacity to oxidize 
fatty acids (126) and exhibit enhanced triacylglycerol clearance (141) compared to their 
less active counterparts.   
Maintaining the health benefits of exercise requires repeated bouts of sufficient 
frequency, intensity and duration (108, 132).  Experimental data in both humans and 
rodents clearly indicate that the benefits of exercise are lost rapidly following exercise 
cessation.  Exercise-induced increases in GLUT-4 protein and insulin-stimulated glucose 
uptake are completely reversed in isolated rat muscle 53 hours following cessation of 
running (84) or 40 hours after cessation of swimming (68).  Insulin action, as assessed by 
an oral glucose tolerance test, is rapidly reduced in endurance-trained individuals upon 
cessation of exercise for 7-14 days (3, 62, 69).  Glucose disposal rate assessed during a 
euglycemic-hyperinsulinemic clamp was reduced by 23% following 10 days without 
exercise in trained men (79).  Similarly, 5 days of detraining in physically-trained 
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subjects elicited a 23% increase in the insulin concentration required to elicit 50% of 
maximal glucose disposal (102), indicative of reduced insulin sensitivity.  Further, 
Burstein et al. (21) observed a significant decrease in glucose clearance rate in athletes 60 
hours after the last exercise bout.  Thus, exercise-enhanced insulin action is rapidly 
reversed by cessation of exercise in as little as several days. 
A number of observational studies also suggest that, over time, reduced physical 
activity levels can lead to insulin resistance and type 2 diabetes and mortality associated 
with the metabolic syndrome (51, 82, 98), which is independent of age (147) and obesity 
status (20, 43, 64, 72, 91, 93, 95, 96, 147).  Powell and Blair (120) estimated that 21% of 
deaths related to diabetes in 1988 were attributable to insufficient physical activity (less 
than 30 min/d or fewer than 5 d/wk of light or moderate physical activities).  Thus, 
experimental and epidemiological evidence suggest reduced physical activity associated 
with exercise has deleterious effects on metabolic processes that over time increase the 
risk for disease (17).  This knowledge has prompted current public health guidelines 
promoting at least 150 min/wk of moderate-intensity or 60 min/wk of vigorous-intensity 
physical activity to optimize metabolic health and reduce disease risk (57).    
2.2 Impact of sedentary behavior and non-exercise activity on disease risk 
Sedentary behavior associated with sitting and non-exercise activity involving 
standing (e.g. housework, stair-climbing, walking at home or work, etc.) also have effects 
on cardiometabolic health (54).  Data from a number of epidemiological investigations 
indicate that the physical activity dose-response curve is steep with a significant increase 
in risk of disease and mortality in those individuals who are the least active (Fig. 2.1) (54, 
56).   
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Figure 2.1 Relationship between physical activity and the risk for coronary heart 
disease/death (adapted from Haskell (56)). 
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epidemiological studies have failed to distinguish the effect of sedentary behavior versus 
lack of physical activity.  Recent data points to the importance of making the distinction 
between participation in physical activity and time spent in sedentary behaviors to 
provide independent measures of the activity spectrum (41, 83).  Recently, several studies 
have suggested that sedentary behavior associated with sitting, distinguished from lack of 
physical activity (i.e. low levels of self-reported leisure-time activities), may have an 
independent effect on aspects of cardiovascular and metabolic health (9, 36, 37, 41, 71, 
128).  Sedentary behavior assessed by self-reported time spent watching television was 
positively associated with triacylglycerol levels and other risk factors for cardiovascular 
disease (83) and blood glucose levels in adults (35, 59, 83), independent of adiposity and 
time spent in physical activity (35, 37). Hu et al. (71) reported that for every 2 hr/d 
increase in television viewing time, risk of diabetes was increased by 14%.   A recent 
study using more objective, accelerometer-based measures of physical activity and 
sedentary behavior reported a significant, positive association between sedentary time 
and 2-hour plasma glucose concentration following an oral glucose challenge, which was 
independent of age, sex, and waist circumference (59).  It should be noted that television 
viewing time was taken to be representative of overall sedentary behavior in the majority 
of these studies.  Although television viewing time has been shown to be most strongly 
associated with risk of type 2 diabetes compared to several other sedentary behaviors (i.e. 
sitting at work or other sitting) (71), television-viewing time constitutes only one 
component of sedentary behavior and it remains unknown the extent to which television 
viewing is representative of overall sedentary behavior (35).  Nonetheless, these studies 
strongly suggest sedentary behavior involving prolonged sitting may be an important 
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modifier of metabolic health independent of obesity status and may mediate effects on 
metabolic function that are distinct from those of physical activity (35). 
Moreover, these studies suggest that a significant reduction in risk of insulin 
resistance and type 2 diabetes can be gained by slight rightward shifts along the physical 
activity continuum (Fig. 2.1), highlighting the importance of daily non-exercise physical 
activity on cardiometabolic health.  For instance, risk for development of type 2 diabetes 
was found to be highest in individuals who accumulated less than 500 kcals of activity 
per week; for each 500 kcal increment in weekly energy expenditure associated not only 
with sports activity, but also with walking and stair climbing, risk for diabetes was 
reduced by 6% (96).  This association remained significant even after adjusting for 
obesity status, hypertension, and family history of type 2 diabetes (96).  Similarly, a more 
recent  study found that while brisk walking reduced the risk of diabetes by 34% for each 
1 hr/d increment, even the activity associated with standing or puttering at home reduced 
diabetes risk by 12% for each 2 hr/d increment (71).  Using accelerometry to objectively 
measure activity, Healy et al. (59) demonstrated a significant effect of low-intensity 
activity on 2-hour postprandial glucose concentration independent of time spent in 
moderate-vigorous activity.   
Taken together, epidemiological evidence suggests that mortality and risk of 
disease cannot simply be ascribed to reductions in exercise.  This underscores the 
significance of an inactivity physiology paradigm recently proposed by Hamilton and 
colleagues (53, 54) that sitting more and performing less non-exercise activity should be 
regarded as classes of behavior distinct from exercise that have independent effects on 
risk for disease (17).   This paradigm emphasizes the importance of maintaining daily 
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non-exercise activity, which has real world relevance because for most individuals, the 
contribution of non-exercise activity to total daily energy expenditure is much greater 
compared to exercise (54, 150).  Viewed in this context, understanding the underlying 
processes and mechanisms responsive to physical inactivity (i.e. reductions in contractile 
activity associated with standing, and ambulation) that promote disease is important (17).  
Whereas the metabolic adaptations to different amounts and types of physical activity 
have been relatively well-characterized, much less is understood regarding the response 
to increasing inactivity.  It may be erroneous to assume that the adaptations to physical 
inactivity are merely opposite to the adaptations to physical activity (17, 54).  In fact, in 
several well-controlled studies performed in rodents, reduced standing and ambulation 
had a much larger negative effect on lipoprotein metabolism than the positive effect of 
adding vigorous exercise training on top of normal daily activity levels (10, 54, 155).  In 
addition, the molecular mechanisms underlying these changes in lipoprotein metabolism 
were distinctly different between inactivity and exercise training (10, 54, 155). 
Limited experimental studies in both animals and humans have investigated the 
metabolic response to short-term and prolonged inactivity.  Because the main focus of the 
present proposal is on the inactivity-induced changes in insulin action and glucose and 
lipid metabolism, the following review of the available literature is focused on the effects 
of inactivity on these metabolic parameters. 
2.3 Experimental data in rodents and humans 
One of the first studies to highlight the importance of standing and postural 
control was performed in mice whose hindlimbs were immobilized with plaster casts to 
significantly reduce contractile activity (131).  In as little as 24 hours following 
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immobilization, insulin-stimulated glucose uptake and glycogen synthesis was 
significantly impaired in isolated soleus muscle (131).  Similarly, hindlimb 
immobilization for 42-48 hours in rats reduced maximum insulin-stimulated glucose 
transport by 42% in isolated skeletal muscle (119).  Thus, these studies provide direct 
evidence that insulin action can be rapidly reduced in response to inactivity in rodents.   
Most of the available information in humans on the effects of inactivity (i.e. 
restriction of standing and ambulation), distinct from detraining (i.e. exercise restriction), 
comes from bed-rest studies with or without head-down tilt to mimic the effects of anti-
gravity.  Significant increases in fasting insulin concentrations were observed after bed 
rest (1, 8, 137, 144), suggesting a decrease in insulin action, although this has not been a 
consistent finding (32, 90, 116).  While Acheson et al. (1) observed a significant increase 
in fasting insulin concentrations after 3 days of head-down bed rest, there was no change 
in fasting levels of this hormone after 3 days of bed rest in the study by Lipman et al. 
(90).  In young, physically-active males, Stuart et al. (137) observed a 44% increase in 
fasting insulin concentrations after just 6 days of bed rest, whereas other studies 
employing similar (100) or more sustained (i.e. 2 weeks) bed rest protocols reported no 
change in fasting insulin levels (32, 116). In contrast, Bergouignan et al. (8) reported a 
22% increase in fasting insulin concentrations after 1 month of bed rest in women.  A 
more consistent finding in the literature, however, is impaired glucose tolerance and 
increased insulin response to an oral glucose load as a result of sustained bed rest in 
healthy subjects (14, 32, 116, 137).  Both outcomes are indicative of reduced insulin 
action, which is usually attributed to a decreased peripheral glucose uptake (90, 100, 
137).   
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Other studies using more direct assessments of insulin action support the finding 
of an inactivity-induced impairment in insulin action.  One of the earliest studies reported 
a reduction in peripheral glucose uptake during a glucose infusion in as little as 3 days of 
bed rest in males (90).    Further declines in peripheral glucose uptake were observed 
after an additional 11 days of bed rest (total 14 days) from 82% of control at 3 days to 
56% of control after 14 days (90).  Insulin infusion after bed rest also resulted in a 
smaller decrease in plasma glucose compared to control, further suggesting a reduction in 
insulin action following inactivity (90).  Several studies employing the glucose clamp 
also report significant reductions in whole-body glucose uptake following 7 days of bed 
rest in men (100, 137). 
While bed-rest studies have provided important information on the direct effects 
of restricted contractile activity on metabolic processes, this model has limited 
applicability for the majority of the general population who are not bed-ridden (54).  
Further, data from prolonged bed rest studies with head-down tilt may be confounded by 
shifts in fluid distribution, muscle atrophy, orthostatic intolerance, etc. (54). 
Very few studies, however, have investigated the effects of non bed-rest inactivity 
models in humans.  The limited data available support the general finding reported in bed 
rest studies that inactivity reduces insulin action.  In a study utilizing 7 days of single leg 
casting to limit ambulatory activity, Richter et al. (125) observed reduced insulin-
stimulated glucose uptake in the vastus lateralis of the casted relative to the non-casted 
leg.  Compared to bed-rest induced inactivity, this model reduced insulin-stimulated 
glucose uptake to a lesser extent, which may be reflective of continued (albeit restricted) 
 12 
muscle activity during ambulatory leg casting and/or less blunting of leg blood flow 
(100).   
Limited data also point to the deleterious effects of significant reductions in non-
exercise activity (e.g. standing, ambulation, and other activities of daily living).  
Recently, Olsen et al. (114) examined the metabolic effects of reduced daily steps (from 
10,000/day to 1500/day) for 2 weeks in healthy, free-living, non-exercising men.  
Compared to baseline, insulin area under the curve in response to an oral glucose 
challenge was increased 57%, indicative of significantly reduced insulin action.  
Experimental reductions in ambulation and standing via prolonged sitting also impair 
insulin action.  Compared to an active condition (i.e. high non-exercise physical activity) 
in which total sitting time was limited to less than 10 minutes per hour, sixteen hours of 
sitting resulted in a 30% reduction in insulin action as assessed by an oral glucose 
challenge (Hamilton and colleagues, unpublished observations).  In summary, select non-
bed rest inactivity paradigms in humans support the general finding of significant 
declines in insulin action following reductions in ambulation, standing, or other non-
exercise activities.   
2.4 Differential effects of inactivity in adipose tissue, liver, and skeletal muscle 
It is likely that skeletal muscle accounts for the majority of the physical inactivity-
induced decline in whole-body insulin action (84) since skeletal muscle accounts for 75-
95% of insulin-stimulated glucose disposal in humans (6).  Additionally, in isolated rat 
muscle, insulin-stimulated glucose uptake is significantly reduced after exercise cessation 
in as little as 40-90 hours after the last exercise bout (68, 75, 124).  However, declines in 
liver (hepatic) insulin sensitivity may also contribute to reductions in whole-body insulin 
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action following inactivity.  In addition to reduced skeletal muscle insulin sensitivity, 
Blanc et al. (14) observed less suppression of hepatic glucose production following 7 
days of bed rest in women, suggesting impaired hepatic insulin sensitivity (14).  
However, no impairment in hepatic insulin sensitivity was observed in men in response to 
a similar inactivity protocol (14, 100, 137), suggesting potential sex differences in the 
physiological response to inactivity.  Reduced adipose tissue insulin sensitivity has also 
been observed in response to inactivity.  Mikines et al. (100) observed similar reductions 
in plasma free fatty acid and glycerol concentrations during a glucose infusion despite 
higher insulin concentrations following 7 days of bed rest indicative of impaired insulin 
suppression of lipolysis.   In summary, reduced skeletal muscle insulin action likely 
accounts for much of the inactivity-induced decline in whole-body insulin action, but 
hepatic and adipose tissue insulin sensitivity may also be reduced.   
2.5 Effect of physical inactivity on substrate metabolism 
 The ability to shift from oxidizing predominantly fat during fasting conditions and 
increase glucose oxidation and suppress lipolysis in response to insulin stimulation 
characterizes the metabolically healthy state, termed metabolic flexibility.  In contrast, 
metabolic inflexibility is characterized by low fat oxidation during fasting conditions and 
impaired insulin-stimulated non-oxidative and oxidative glucose disposal.  Originally, 
metabolic flexibility and inflexibility referred to substrate use profiles observed in 
skeletal muscle of lean and obese individuals (76).  However, because skeletal muscle 
strongly influences whole-body metabolism, these terms can also be used to characterize 
whole-body substrate metabolism (136).  
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A number of reports suggest that inactivity is associated with a substrate use 
profile characteristic of metabolic inflexibility.  In mice, hindlimb immobilization 
significantly reduced insulin-stimulated glycogen synthesis and glucose oxidation in 
isolated soleus muscle (131).  Hindlimb unloading for 9 days reduced the capacity to 
oxidize long-chain fatty acids by 37% and increased reliance on carbohydrate utilization 
(5), supporting the hypothesis that fatty acid oxidation is reduced in response to 
inactivity.  In humans, non-oxidative glucose disposal, which mainly reflects glycogen 
storage, was lower and glucose oxidation tended to be lower following 7 days of bed rest 
in humans during a glucose clamp at a relatively low insulin infusion rate (100).  After 
bed rest, non-oxidative glucose disposal was also lower at high insulin infusion rates 
(100).  Limited data in humans also suggests that fatty acid oxidation is altered following 
inactivity.  After 7 days of head-down bed rest, fasting lipid oxidation was reduced by 
~80% in both men and women (14).  Similarly, in a study by Ritz et al. (127), fat 
oxidation during fasting was significantly lower and carbohydrate oxidation higher 
following long-term simulated microgravity (42 days).  In addition, both fasting and 
insulin-stimulated levels of lipogenesis were significantly increased in women following 
7 days of bed rest (14). However, not all studies suggest altered substrate oxidation 
following inactivity.  Acheson et al. (1) reported that in response to 3 days of bed rest 
with head-down tilt, fat oxidation during fasting was significantly increased, while 
carbohydrate oxidation in response to a glucose load was unchanged.  Despite this 
inconsistent finding, the majority of the human studies support the hypothesis that 
inactivity shifts fasting substrate metabolism toward increased reliance on carbohydrate 
utilization and reduced reliance on fat oxidation and impairs insulin-stimulated glucose 
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oxidation and suppression of lipolysis, all of which are characteristic features of 
metabolic inflexibility.  
2.6 Mechanisms underlying inactivity-induced changes to insulin action 
While the mechanisms responsible for the beneficial effects of exercise are well-
studied, the cellular mechanisms involved in the rapid inactivity-related decline in insulin 
action are not well-characterized.  Mechanisms to explain observed decrements in insulin 
action in response to inactivity may involve: changes in circulating levels of 
counterregulatory hormones (144); decreased blood flow to the inactive muscles (100); 
reductions in glucose transporters (GLUT-4) (138, 145); changes in the activity of 
enzymes involved in glucose metabolism such as glycogen synthase (100, 109); increased 
muscle glycogen concentration (44, 68, 75); and/or alterations in insulin receptor 
signaling (84).   
Changes in the concentrations of counterregulatory hormones influencing glucose 
uptake (e.g. cortisol, growth hormone, glucagon, epinephrine) have been linked to 
reduced insulin action following inactivity.  Increased plasma cortisol levels were linked 
to the reduction in peripheral glucose utilization in men following 30 days of bed rest 
(144).  Increased growth hormone concentrations after 20 days of bed rest in humans 
have also been associated with decreased tissue sensitivity to insulin (144).  However, 
other shorter duration bed rest studies (3-14 days) report unchanged levels of 
counterregulatory hormones (90, 100, 116), suggesting a possible time lag in the 
counterregulatory hormone response to inactivity.   Because changes to insulin action in 
response to inactivity occur rapidly (119, 131) and can precede changes in 
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counterregulatory hormones, there is little evidence to suggest a significant role for these 
hormones in changes to insulin action (90). 
Leg blood flow is reduced after 7 days of bed rest, which may decrease glucose 
availability to skeletal muscle and contribute to the reduction in glucose uptake following 
inactivity (100).  Blood flow has been positively correlated with glucose uptake in 
skeletal muscle of rats (45).  However, in humans, blood flow does not appear to 
independently mediate insulin-stimulated glucose uptake (110, 121).  Thus, reduced 
blood flow may not be a plausible mechanism to explain inactivity-related declines in 
insulin action. 
Lower insulin-stimulated glycogen synthase activity may contribute to reduced 
insulin action in skeletal muscle in response to inactivity (109) although evidence to 
support this is scarce (100).  In rodents, activation of glycogen synthase by insulin was 
reduced following hindlimb immobilization (109), although this observation may be 
confounded by a slightly higher basal activity of the enzyme after immobilization (100).  
In humans, the activity of glycogen synthase during a euglycemic-hyperinsulinemic 
clamp was unaltered following 7 days of bed rest (100).  
 In rodents, insulin-stimulated glucose uptake is inversely related to muscle 
glycogen concentration (44, 65, 75, 124).  Thus, glycogen may mediate reductions in 
insulin action following inactivity.  However, insulin-stimulated glucose uptake was 
lower following 53 hours of restricted voluntary running in rats compared to 29 hours of 
restricted running despite no difference in muscle glycogen concentrations (84), which 
argues against a regulatory role of muscle glycogen in the inactivity-induced decline in 
insulin action (84). 
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More likely mechanisms to explain lower insulin action following inactivity are 
decreased glucose transport capacity (145), changes in insulin receptors, and/or 
alterations in insulin receptor signaling (84).  A reversal of the adaptive increase in 
GLUT-4 transporters has been associated with the decline in insulin-stimulated glucose 
uptake following detraining in rodents (68, 75, 84, 124).  However, Ploug et al. (119) 
reported no change in GLUT-4 protein concentration in rat hindlimbs following 42-48 
hours of immobilization.  Conversely, in humans both short-term (145) (6 days) and 
longer-term (138) (19 days) inactivity studies report significant reductions in GLUT-4 
transporter levels. In a study by Vukovich et al. (145), lower insulin-mediated glucose 
uptake following inactivity was directly related to lower GLUT-4 transporter protein 
concentration. 
Although not a consistent finding (119), results from a recent study by Kump and 
Booth (84) suggest that alterations in insulin receptor binding and/or signaling mediate 
the reduction in insulin-stimulated glucose uptake following reduced activity.  Insulin 
binding, IRβ protein concentration, insulin-mediated IRβ tyrosine phosphorylation, and 
Akt Ser473 phosphorylation were reduced to sedentary values following 53 hours of 
prohibited running in rats.  These changes coincided with the decline in submaximal 
insulin-stimulated glucose uptake, suggesting a potential mechanism for the reduction 
(84).  Following  42-48 hours of hindlimb immobilization, however, Ploug et al. (119) 
reported no changes in insulin receptor binding or insulin receptor kinase activity. The 
discrepancy in the results between these two studies may reflect differences in the 
inactivity protocols, rat strains, or methodologies used to determine insulin receptor 
binding or insulin signaling.  Regardless, the diversity of findings suggests that the 
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mechanism to explain the reduction in insulin action in response to inactivity is 
multifactorial and complex. 
2.7 Effect of energy imbalance on the metabolic response to inactivity 
Reductions in insulin action following inactivity may also be related to energy 
imbalance.  Restriction of contractile activity associated with inactivity reduces overall 
energy expenditure and energy demand.  Thus, energy surplus (greater energy intake 
relative to expenditure) and inactivity often coexist because maintaining energy balance 
during extended periods of low muscle activity requires a large reduction in daily energy 
intake.   
Thus, the effects of inactivity on glucose metabolism may be confounded by a 
greater supply of energy relative to decreased energy expenditure (i.e. energy surplus).  
Energy surplus is associated with insulin resistance and may play a role in the 
pathogenesis of type 2 diabetes (81).  Chronic energy oversupply leads to body weight 
gain over time, which contributes significant risk for developing insulin resistance and 
type 2 diabetes (107).  Reduced insulin action, however, appears be an early metabolic 
adaptation to energy surplus (111, 115) which occurs prior to significant changes in body 
weight (4, 52, 113, 146).  The rapid changes to glucose metabolism as a result of energy 
surplus mimic the adaptations to inactivity.  Thus, energy surplus may be a key 
modulator of the effects of physical inactivity on insulin action and substrate metabolism.   
In obesity-prone rats, 3 days of overfeeding (an approximate doubling of caloric 
intake) impaired the action of insulin to suppress hepatic glucose production, and within 
7 days the rate of glucose uptake in skeletal muscle was also significantly decreased 
(146).  In our laboratory, we have demonstrated that a short period of energy surplus 
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coupled with a reduction in structured exercise is sufficient to reduce insulin action by 
~30% in healthy, active humans (52).  A bout of exercise performed in a state of energy 
surplus reversed the decline in insulin action, but did not return to baseline values (52).  
Thus, these results suggest an independent effect of energy surplus on insulin action (52).  
Therefore, it is plausible that the decline in insulin action due to inactivity may be, at 
least in part, due to an excess of nutrient availability relative to the reduced metabolic 
demand (energy surplus).   
Although no studies to date have directly tested this hypothesis, results from a 
study in young men by Dolkas and Greenleaf (32) indirectly supports the hypothesis that 
energy surplus may mediate changes to insulin action in response to inactivity.  The study 
authors compared insulin and glucose responses to an oral glucose tolerance test between 
4 conditions: a 2-wk ambulatory control (total daily energy expenditure ((TDEE)) = 
~3000 kcal); 2-wk bed rest with intermittent isotonic exercise (TDEE = ~ 2940); 2-wk 
bed rest with intermittent isometric exercise (TDEE = ~ 2410); and 2-wk bed rest with no 
exercise (TDEE ~2160 kcal).  There was a linear inverse relationship between estimated 
energy expenditure and insulin area under the curve (r=0.99) (Fig. 2.2), suggesting 
energy expenditure is strongly related to the insulin action response to inactivity (32).  
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Figure 2.2 Regression of integrated area under insulin response curves during glucose 
tolerance tests on 24-hr energy expenditures for 3 bed-rest protocols and 1 ambulatory 
control.   Redrawn from Dolkas et al. (32). 
  
 
Alternatively, because energy intake was constant among the 4 conditions (3073 
kcal/day), differences in energy imbalance ( 	
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could also explain differences in the insulin response to oral glucose.  In fact, a plot of 
insulin area and the difference between energy intake and energy expenditures in the 4 
conditions indicates a clear positive relationship between the two variables (Fig. 2.3).  
The apparent relationship between insulin area in response to oral glucose and energy 
surplus suggests a role for energy surplus in mediating the change in insulin action in 
response to inactivity. 
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Figure 2.3 Relationship between area under insulin response curves during glucose 
tolerance tests and energy surplus (energy intake - energy expenditure) for 3 bed rest 
protocols and 1 ambulatory control.  Adapted using results from Dolkas et al. (32). 
 
 
However, data from one carefully controlled bed-rest study suggests that the 
relationship between energy surplus and the change to insulin action in response to 
inactivity may be more complex.  Insulin-stimulated glucose uptake during a euglycemic-
hyperinsulinemic clamp was reduced by approximately 25% following 3 days of bed rest 
coupled with a high-fat diet (135).  Daily energy intake was reduced by approximately 
500-600 kcals (from 1.6 x RMR to 1.2 x RMR), lower insulin action cannot be explained 
by energy imbalance.  Conversely, when inactivity was coupled with a high-carbohydrate 
diet with the same reduction in energy intake, insulin-stimulated glucose uptake was not 
reduced, suggesting that dietary composition, rather than energy balance, modulates the 
inactivity-related response to insulin action, although this conclusion is tenuous since the 
role of energy balance was not directly tested in this study.  Alternatively, because high-
fat feeding for 3 days without restriction of physical activity did not impair insulin action 
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action following inactivity.  Instead, the story may be more complex and macronutrient 
composition may also play a role in the response to inactivity.  
2.8 Role of dietary composition on insulin action 
Some evidence suggests that macronutrient composition of the diet affects the 
insulin action response to energy surplus.  In particular, a nutrient oversupply of fatty 
acids may exert a more potent negative effect on insulin action than an oversupply of 
carbohydrate.  In lean, healthy, sedentary individuals, an increased availability of 
circulating fatty acids via lipid infusion (34, 40, 139) or an increase in dietary fat (92) 
impairs insulin action (34, 92), ostensibly via fatty-acid induced impairment in insulin 
signaling in skeletal muscle (154), although this is not a universal finding (42).  In a study 
directly comparing the metabolic response to a high-fat (~55-60% fat) versus high-
carbohydrate diet (62-64% carbohydrate) in humans, Bachman et al. (4) observed a 
significant reduction in insulin action after 3 days on the high-fat diet, whereas no 
differences were observed following the high-carbohydrate diet.  However, the associated 
decline in insulin action in the high-fat condition is confounded by a greater energy 
intake relative to the high-carbohydrate condition (~ 767 kcal/day) (4), thus it is unclear 
from this study whether there is a true independent effect of increased dietary fat 
composition on insulin action.  However, the results of a recent carefully-controlled study 
suggest there is no independent effect of an increase in dietary fat composition on insulin 
action.   Following 6 days of a high-fat diet (75% energy as fat), insulin action assessed 
during a euglyemic-hyperinsulinemic clamp was not impaired relative to insulin action 
measured 6 days following an isocaloric low-fat diet (35% energy as fat) (22).  In fact, 
during the last 30 minutes of the clamp, glucose disposal was greater following the high-
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fat diet compared to the low-fat diet (22).  Thus, when energy intake is carefully 
controlled, an increase in dietary fat composition appears to minimally affect insulin 
action. 
Results from studies investigating the effects of a surplus of dietary carbohydrate 
on insulin action in humans are less clear.  Following administration of 50% excess 
energy predominantly in the form of carbohydrate, plasma insulin concentrations were 
significantly higher and hepatic glucose production greater, indicative of reduced hepatic 
insulin sensitivity (129). However, four days of carbohydrate feeding did not affect the 
insulin or glucose response to an oral glucose load in lean or obese men and women 
despite an excess mean energy intake of ~1816 kcal/d and ~2100 kcal/d, respectively 
(103).   
Thus, excess carbohydrate may affect insulin action differently than excess fat.  
Nonetheless, short-term overfeeding without alterations in dietary composition 
(proportional increases in fat, carbohydrate, and protein) has been shown to reduce 
insulin action in humans (106, 113).  Therefore, the available data suggests that energy 
surplus exerts a clear negative effect on insulin action, irrespective of dietary 
composition.   
2.9 Effects of energy surplus on substrate metabolism 
 Energy surplus also shifts fasting substrate oxidation toward increased 
carbohydrate oxidation and decreased fat oxidation.  In Pima Indian men, 5 days of 
overfeeding (equivalent increases in macronutrients) reduced 24-hour fat oxidation and 
increased carbohydrate oxidation (86).  In addition, four days of carbohydrate 
overfeeding has also been show to suppress lipid oxidation and increase plasma 
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triacylglycerol levels in both lean and obese subjects (103).  Lower insulin-stimulated 
glucose uptake following energy surplus may also translate into reduced insulin-
stimulated non-oxidative and oxidative disposal.  However, although non-oxidative 
glucose disposal was reduced in response to an oral glucose load, oxidative glucose 
disposal increased following carbohydrate overfeeding (103).  Similarly, a 62% increase 
in energy intake for 14 days reduced non-oxidative glucose disposal, but increased 
carbohydrate oxidation (106).  Thus, though energy surplus reduces lipid oxidation 
during fasting conditions, insulin-stimulated carbohydrate oxidation appears unaffected.  
Nonetheless, increased plasma triacylglycerol levels and decreased fat oxidation are 
indicative of a metabolic state associated with the development of insulin resistance 
(123).   
2.10 Mechanisms linking increased energy intake to decreased insulin action 
A surplus of carbohydrate calories is stored as glycogen (129).  Insulin action is 
inversely correlated with muscle glycogen (28).  Thus, increases in muscle glycogen or 
changes in the activities of glycogen-dependent proteins (e.g. glycogen synthase) may be 
potential mechanisms to explain the reduction in insulin action following energy surplus.  
In a study by Mott et al. (106), a 62% increase in energy intake for 13 days reduced both 
fasting and insulin-stimulated glycogen synthase activity in skeletal muscle (106).  Non-
oxidative glucose disposal was also reduced in response to supra-physiological insulin 
levels, suggesting reduced insulin action.  However, reduced glucose disposal was not 
related to changes in glycogen synthase activity or glycogen concentration, suggesting 
other mechanisms may be involved in the change to insulin action following energy 
surplus.  Of note, however, subjects who exhibited the greatest decreases in glycogen 
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synthase activity also had the largest increases in fasting insulin concentrations following 
the overfeeding protocol (106).  Thus, alterations in glycogen synthase activity may 
contribute to impaired glucose metabolism following energy surplus.   
2.10.1 Nutrient fuel sensors involved in the regulation of energy balance and insulin 
action 
Increased availability of both glucose and free fatty acids may initiate a cellular 
response that contributes to the reduction in insulin action.  Nutrient oversupply of free 
fatty acids by lipid infusion impairs insulin-stimulated glucose uptake via effects on key 
components of the insulin-signaling cascade (81).  Elevations in both glucose and free 
fatty acids have been shown to activate PKC isoforms (50, 73, 85, 88), which may lead to 
phosphorylation of serine/threonine residues on the insulin receptor and a subsequent 
impairment in insulin signal transduction (81).  Thus, activation of PKC isoforms within 
skeletal muscle may be involved in reduced insulin-stimulated glucose uptake following 
energy surplus.  Additionally, increased free fatty acids as well as glucose availability 
may also upregulate the hexosamine biosynthetic pathway (HBP) (58, 81).  This pathway 
is hypothesized to serve as an energy sensor responsive to a surplus of calories which 
may modulate insulin action (111, 112, 149).  Most of the glucose entering skeletal 
muscle is directed towards glycogen synthesis or glycolysis.  However, a small 
percentage of glucose enters the HBP after conversion to fructose-6-phosphate.  The 
enzyme fructose-6-phosphate-amidotransferase (GFAT) catalyzes the conversion of 
fructose-6-phosphate to glucosamine-6-phosphate and regulates flux through the 
pathway.  The final step in HBP is the formation of uridine diphosphate N-
acetylglucosamine (UDP-GlcNAc), a main substrate for protein glycosylation (111, 149).  
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Early observations that inhibition of GFAT could prevent hyperglycemia-induced insulin 
resistance suggested a role for the HBP as an energy sensor modulating insulin action 
(111, 149).  Further, UDP-GlcNAc levels are also responsive to changes in nutrient 
intake.    In rats, UDP-GlcNAc levels were 68% higher following overfeeding compared 
to controls (146). Conversely, calorie restriction reduces UDP-GlcNAc levels, further 
implicating its role as an energy sensor (46). Although HBP is most sensitive to changes 
in glucose, increased dietary fat availability also leads to increased flux through HBP and 
UDP-GlcNAc in skeletal muscle (58).  
HBP activation via glucosamine administration increases UDP-GlcNAc 
concentrations and reduces insulin-stimulated glucose uptake (115, 149).  Overexpression 
of GFAT in skeletal muscle and adipose tissue in mice also induces insulin resistance 
(63), further suggesting a link between HBP and insulin action (111). It is postulated that 
key proteins of the insulin-signaling pathway may undergo posttranslational modification 
via glycosylation with UDP-GlcNAc, potentially explaining a mechanism by which HBP 
activation reduces insulin-stimulated glucose uptake (111, 115).  Activation of HBP has 
been shown to downregulate genes involved in oxidative phosphorylation and fatty acid 
oxidation in rat skeletal muscle (112), which may indirectly reduce insulin action.   
Malonyl-CoA levels may also serve as a fuel sensor that may regulate substrate 
oxidation in response to energy surplus (111).  Malonyl-CoA is an intermediate in fatty 
acid synthesis and inhibits carnitine palmitoyl transferase-1 (CPT1), which controls 
transport of free fatty acids into the mitochondria for oxidation.  High concentrations of 
both glucose and insulin increases malonyl-CoA levels and suppresses lipid oxidation 
(111, 122).  Decreased capacity to oxidize free fatty acids may increase the intracellular 
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pool of fatty acid moieties, which may impair insulin action via fatty acid inhibition of 
insulin signal transduction discussed above (81).  In summary, increased energy intake 
may induce multiple and complex mechanisms involved in the regulation of energy 
balance and insulin action (111). 
2.11 Summary 
 Data from hindlimb suspension studies in rodents and bed rest studies in humans 
indicate that inactivity exerts clear deleterious effects on insulin action and lipid 
metabolism.  However, no published studies have examined the metabolic impact of a 
more relevant mode of inactivity, i.e. prolonged sitting in humans.  Energy surplus causes 
similar impairments to insulin action and lipid metabolism. Thus, the effects attributed to 
inactivity may be confounded by a concurrent energy surplus. However, to our 
knowledge, no studies have investigated the combined effect of a high calorie diet and 
inactivity on insulin action.  Therefore, the aims of this study were to evaluate the effects 
of short-term inactivity (sitting) with or without energy surplus on insulin action.   
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CHAPTER 3  
METHODOLOGY 
3.1 Overall design 
An overview of the study design is shown in Figure 3.1.  A cross-over design was 
used in which each subject completed 3 experimental conditions. Each condition required 
a 24-hour laboratory stay and the order of the conditions was counter-balanced across 
subjects.  In 2 conditions, subjects remained seated for ~16 of the 24 hours to restrict 
physical activity (INACTIV and INACTIV LO-CAL).  The 3rd condition served as an 
active condition in which subjects stood and performed activities of daily living for 
approximately 12 of the 24 hours (ACTIV).  All meals (i.e. breakfast, lunch, and dinner) 
were provided throughout the 24-hour period. For ACTIV, energy intake approximated 
energy expenditure (i.e. energy balance). Energy intake in INACTIV was identical to that 
in ACTIV (energy intake > energy expenditure, i.e. energy surplus). In INACTIV LO-
CAL, energy intake was reduced to more closely match the lower energy expenditure (i.e. 
energy balance) (Table 3.1). Insulin action was measured in the morning approximately 
12 hours following the evening meal in each condition. 
Figure 3.1 Overview of study design 
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Table 3.1 Average energy intake and expenditure across conditions (M ± SD). 
 
Energy Intake 
(kcals/day) 
Energy Expenditure 
(kcals/day) 
Energy Balance 
(EI-EE) 
(kcals/day) 
ACTIV 3106 ± 590
a
 2944 ± 462 162 ± 248a 
INACTIV 3133 ± 583
a
 2195 ± 424b 938 ± 202a 
INACTIV LO-CAL 2109 ± 428 2139 ± 427
b
 -30 ± 82 
a
 Significantly different from INACTIV LO-CAL 
b Significantly different from ACTIV 
3.2 Subjects 
Fourteen men (n=7) and women (n=7) between the ages of 20 and 32 years (26.1 
± 4.5) were recruited from the surrounding area by flyers and advertisements to 
participate in this study.  Each subject completed all 3 trials except for one male and one 
female who only completed 2 out of 3 trials due to an adverse event and time constraints, 
respectively (ACTIV and INACTIV; and ACTIV and INACTIV LO-CAL, respectively). 
Subject characteristics are presented in Table 3.2. All volunteers were in good health, of 
normal body composition (23.7% body fat), and aerobically fit (VO2peak = 49.1 mg•kg-
1
•min-1).  All subjects were recreationally active, meeting the physical activity guidelines 
(i.e. at least 30 minutes of moderate exercise, 3 days a week or more) as determined by a 
generic physical activity questionnaire.  All subjects were non-smoking, free of known 
disease (e.g. cardiovascular disease, type 2 diabetes, etc.), not following a very low or 
very high-carbohydrate diet (<30% or >70% carbohydrate, respectively), and were not 
taking any medications (e.g. metformin, insulin, statin drugs) or supplements (e.g. 
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chromium, vanadium, ephedra) known or suspected to alter carbohydrate or lipid 
metabolism. Four females were taking monophasic birth control. The study protocol was 
approved by the Institutional Review Board at the University of Massachusetts, Amherst 
prior to initiation of the study and all subjects gave their verbal and written informed 
consent before participating.  
Table 3.2 Subject characteristics (n=14; 7M, 7F) 
 Average (M ± SD) Range 
Age (years) 26.1 ± 4.5 19.8 – 32.2 
Weight (kg) 69.5 ± 13.2 49.6 – 89.7 
Height (cm) 170.9 ± 10.1 152.0 – 188. 
BMI 23.6 ± 3.0 18.8 – 29.2 
% Fat 23.7 ± 7.1 13.0 – 36.6 
Lean mass (kg) 53.4 ± 13.4 35.6 – 78.0 
VO2peak (mg•kg-1•min-1) 49.1 ± 3.3 40.5 – 52.4 
Physical activity (hrs/week) 2.8 ± 1.2 1.5 – 8.0 
 
3.3 Preliminary testing 
Prior to participating in the experimental protocol, body composition (fat mass, 
fat-free mass, and % body fat) was assessed by dual energy x-ray absorptiometry 
(DEXA) (Lunar, Madison, WI).  Subjects completed a graded, continuous exercise test 
on a treadmill (LifeFitness 9100 HR, Schiller Park, IL) to assess peak oxygen 
consumption (VO2peak).  The test commenced at a low work rate (e.g. 5.0 miles per hour) 
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with incremental increases in treadmill grade (e.g. +2% every 2 minutes) and/or speed 
(e.g. +0.5 miles per hour) until a peak voluntary effort was achieved.  Gas exchange 
measurements were obtained continuously throughout the test by open-circuit spirometry 
(TrueMax2400 Metabolic Measurement System, Parvomedics, Salt Lake City, UT).  
Heart rate was measured and recorded throughout the test by telemetry using a Polar 
monitor (Polar Electro Oy, Kempele, Finland).  Peak effort was defined as achievement 
of at least two of the following criteria: 1) RER ≥ 1.10; 2) peak heart rate ≥ 95% of age-
predicted maximum (220-age) and 3) a plateau in VO2 as defined by an increase of < 150 
ml·kg·min-1 between the penultimate and final stage of the test.  All of the subjects 
achieved at least two of these three criteria and all tests were considered a valid 
assessment of peak oxygen consumption. 
Daily physical activity was assessed 2-4 days prior to each trial using an activPal 
professional physical activity monitor (PAL Technologies Ltd, Glasgow, Scotland). The 
activPal physical activity monitor is a single unit monitor based on a uni-axial 
accelerometer that is worn midline on the anterior aspect of the thigh.  It produces a 
signal related to thigh inclination and can sense periods of walking, sitting and standing 
and is thus useful for measuring both activity and inactivity.  The monitor also records 
step count and cadence.  A software package (activPAL Professional Research Edition) 
summarizes activity over 1 hour periods in graphical and numeric formats based on 
proprietary algorithms. The activPAL has been shown to be a valid and reliable 
measurement tool for determining posture and motion during activities of daily living in a 
healthy population (48). Subjects were instructed to wear the monitor on the midline of 
the right thigh. These data were used to objectively quantify each subject’s habitual 
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activity levels and energy expenditure during typical exercise and non-exercise days.  
The data were also used to determine any potential impact of prior physical activity and 
energy expenditure on outcome measures during the study.  The activPal was also worn 
during all 24-hour laboratory visits. These data was used to quantify 24-hour energy 
expenditure during the 3 conditions (i.e. 8 A.M. – 8 A.M.).   
3.3.1 Estimated energy expenditure and energy intake 
To estimate total daily energy expenditure (TDEE) and energy intake in this 
sample, we have previously used the protocol described below (12, 52).  Resting energy 
expenditure (REE) was measured in the morning after an overnight fast.  Upon arrival, 
subjects lay supine in a quiet room for 30 minutes.  A ventilated hood was placed over 
the subject’s head and respiratory gases were collected using indirect calorimetry 
(TrueMax2400 Metabolic Measurement System, Parvomedics, Salt Lake City, UT) for 
30 minutes.  To estimate energy requirements for the day prior to each 24-hour laboratory 
visit, the REE was multiplied by an activity factor varying between 1.5-1.7 based on 
habitual physical activity as determined by questionnaire.  Energy requirements estimated 
from REE using the appropriate activity factor are strongly correlated (r= 0.73) with 
energy requirements measured during 28 days of controlled feeding (78).  Energy 
requirements during ACTIV and INACTIV were calculated by multiplying REE by 2.05 
and requirements during INACTIV LO-CAL were calculated using a factor of 1.39 * 
REE based on estimates provided by Hamilton and colleagues (personal communication) 
using study designs similar to ours.  Subjects were provided with all meals the day prior 
to, and the day of, each 24-hour laboratory visit in order to control energy intake.  Meals 
consisted of commercially prepared frozen entrees and foods prepared and weighed in the 
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Energy Metabolism Laboratory (e.g. cereal, bagel, fruit, peanut butter, etc.).  Subjects 
were asked to consume all food provided as discrete meals at certain times of the day 
(breakfast, lunch, dinner, etc.).  Subjects were instructed to refrain from alcohol and 
caffeine for 24 hours prior to each 24-hour laboratory visit. Average daily macronutrient 
composition on the day prior to the 24-hour intervention was 55% carbohydrate, 29% fat, 
and 16% protein; average daily macronutrient composition during the 24-hour 
intervention was 54% carbohydrate, 29% fat, and 16% protein.  
3.3.2 Control for menstrual cycle phase 
Although the data are not consistent, some studies show that insulin sensitivity is 
lower in the luteal phase of the cycle compared with the follicular or menstrual phase (31, 
142, 153). As previously mentioned, 4 females were taking monophasic birth control so 
all testing was conducted in a single cycle phase in these women. Based on self-reported 
onset and cessation of menses, one female completed all experimental conditions in the 
luteal phase; one completed 2 conditions in the luteal and the 3rd condition (ACTIV) in 
the follicular phase. For one woman with a history of irregular menstrual cycles, it was 
impossible to determine menstrual cycle phase during any experimental condition. 
However, because all but 2 female subjects completed all experimental conditions in a 
single cycle phase, results of this study were likely unaffected by variations in menstrual 
cyclicity. 
3.4 Experimental protocol 
Subjects completed three, 24-hour visits to the laboratory in a counter-balanced 
order with at least a week between visits.  Three days prior to arrival in the laboratory 
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(Day -3), subjects were asked to perform 30 minutes of moderate exercise (e.g. jogging, 
cycling, etc.) at approximately 8 P.M. Subjects were instructed to perform the same 
exercise bout (i.e. same mode, duration, and intensity) before each visit. For the 2 days 
prior to each 24-hour intervention, subjects were instructed to refrain from any structured 
exercise (i.e. no physical activity beyond activities of daily living). All meals were 
provided the day prior to each 24-hour visit (Day -1) and were standardized across 
conditions.  Average energy intake on Day -1 was 2321 ± 506 kcal/day. Daily 
macronutrient composition was 55% carbohydrate, 29% fat, and 16% protein.  On the 
morning of Day 1, approximately 12 hours after the evening meal, subjects reported to 
the Energy Metabolism Laboratory for the 24-hour visit.  Upon arrival, subjects were 
seated and a butterfly needle was inserted into a forearm vein and 5 ml of blood was 
drawn for the measurement of fasting plasma triacylglycerol concentration.  Subjects 
were then given a standardized breakfast to eat and were shown to their designated room 
equipped with a chair, desk, and futon.  Subjects were provided access to a computer with 
internet service, books and magazines, or movies throughout the day and evening.  A 
standardized lunch and dinner were given at approximately 12 P.M. and 5 P.M., 
respectively.  After an overnight stay in the laboratory, insulin action was assessed in the 
morning (Day 2) approximately 10-12 hours following the evening meal.  
During ACTIV, total sitting time throughout the day was restricted and subjects 
sat for approximately 32% of total waking hours (Table 3.3), which is less than the 
amount of sedentary time in a typical individual (i.e. 55% of the waking day) (97). 
Subjects stood while reading, talking on the phone, or working on the computer, walked 
at a low to moderate intensity (≤ 3 mph) or performed activities of daily living (e.g. 
 35 
sweeping, bending to pick up books, vacuuming, etc.).  All subjects were instructed to 
perform standardized tasks and activities at specific times during the day based on an 
activity “menu”.  The energy expenditure goal for 24 hours was 2.05 * REE.  To create 
the menu, low-intensity activities (≤ 3.8 METs) were chosen from a list of select 
household activities (e.g. sweeping, dusting, vacuuming, dish washing, etc.) with directly 
measured MET values from a study of 102 individuals (Freedson et al. unpublished data).  
Three additional activities with estimated MET values were selected from the Physical 
Activity Compendium (i.e. dart throwing, take out trash, put away groceries) (2).  A 
sample schedule of activities is provided in Appendix A.  During INACTIV and 
INACTIV LO-CAL, walking and standing was restricted and subjects spent 
approximately 98% of the waking day sitting (Table 3.3), which is much greater than the 
amount of time spent in sedentary behaviors in a large population sample in the United 
States (i.e. 55%) (97).  A wheelchair was provided to transport the subjects within the 
laboratory and building.  Energy expenditure during these two conditions was 
approximately the same (2195 ± 424 and 2139 ± 427 for INACTIV and INACTIV LO-
CAL, respectively) and was significantly less than energy expenditure during ACTIV 
(2944 ± 462).  
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Table 3.3 Total sitting, standing, stepping, and sleep time during the 3, 24-hour conditions (M±SD). 
 
 
Sitting Time 
(hrs) 
Standing Time 
(hrs) 
Stepping Time 
(hrs) 
Sleep Time 
(hrs) 
Total steps 
(steps/day) 
ACTIV 5.8 ± 1.7 9.8 ± 0.5 2.2 ± 0.4 6.1 ± 1.3 9913 ± 1669 
INACTIV 16.9 ± 1.0
a
 0.2 ± 0.2a 0.1 ± 0.1a 6.8 ± 1.1a 264 ± 0.4a 
INACTIV LO-CAL 16.8 ± 1.5
a
 0.3 ± 0.1a 0.1 ± 0.0a 6.8 ± 0.6a 251 ± 195a 
a
 Significantly different from ACTIV. 
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3.4.1 Standardized meals 
The energy content and composition of the evening meal (3 personal cheese 
pizzas and a Swiss cheese wedge) was identical both between subjects and across all 
conditions (1030 kcals, 39% fat, 18% protein, 43% carbohydrate) in order to standardize 
the effect of the previous meal on insulin action.  The meal was also identical in content 
and composition to the meal consumed on the evening of Day -1 to allow for the 
comparison of fasting triacylglycerol concentrations from Day 1 to Day 2 without the 
potential confounding effect of the prior meal. The carbohydrate composition of breakfast 
and lunch was increased so that average daily macronutrient composition on Day 1 was 
54% carbohydrate, 29% fat, and 16% protein.  Breakfast and lunch consisted of solid 
foods (e.g. cereal, bread, deli meats), juice, or non-caffeinated soft-drink beverages.  For 
all conditions, dietary composition, the timing of meals, and the time interval between the 
evening meal and the measurement of insulin action was held constant.  However, the 
energy content of breakfast and lunch on Day 1 was lower in INACTIV LO-CAL 
compared to INACTIV and ACTIV.  Total daily energy intake was the same in ACTIV 
and INACTIV (3106 ± 590 and 3133 ± 583, respectively), but energy intake in INACTIV 
LO-CAL was reduced to approximate the reduction in energy expenditure (2109 ± 428).  
Subjects were allotted 25 minutes to eat each meal.    
3.5 Assessment of insulin action and other metabolic variables 
Ten to 12 hours after the evening meal, insulin action was assessed using a 1-hour 
continuous infusion of 20% glucose that contained a 2% stable [6,6-2H] glucose isotope 
tracer (Cambridge Laboratories, Andover, MA), as previously described (12, 134).  
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Indwelling catheters were placed in a superficial vein of each forearm for venous blood 
sampling and continuous infusion of the isotope tracer.  Venous blood samples were 
collected to determine naturally occurring levels of isotopic enrichment prior to the 
infusion.  These samples were also used to compare changes in fasting triacylglycerol 
levels from Day 1 to Day 2. A priming bolus of 200mg [6,6-2H] glucose was given 
followed by a 90-minute infusion of 2.0% [6,6-2H] glucose isotope at a rate of 3.0mg/min 
delivered by a peristaltic infusion pump (Harvard Apparatus Pump 22, Holliston, MA). 
Respiratory gases and venous blood samples were collected at 0, 75 and 90 min.  At 90-
min, the infusate was changed to 20% dextrose containing 2.0% [6,6-2H] glucose 
delivered at a rate of 8.45mg/kg FFM/min for 60 min.  Blood samples and respiratory 
gases were collected at 50, 55, and 60 minutes of the glucose/stable isotope infusion to 
determine glucose rate of appearance (Ra) and disappearance (Rd) as well as plasma 
concentrations of glucose and insulin.  Glucose and insulin concentrations from minutes 
50, 55, and 60 were averaged to determine the steady-state glucose (SSPG) and insulin 
(SSPI) concentrations.  Insulin action was determined using the isotopically-determined 
glucose uptake scaled to steady-state insulin concentrations during the continuous 
infusion.  This procedure for the assessment of insulin action was identical among the 
three different treatment conditions. 
3.6 Blood collection and biochemical analysis 
 Venous blood was collected in vacutainers containing a glycolytic inhibitor 
(sodium fluoride) and potassium oxalate for analysis of glucose and glucose isotopic 
enrichment. In addition, vacutainers containing EDTA were used for the analysis of 
insulin, triacylglycerols, and free fatty acids. After collection, samples were immediately 
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centrifuged at 3300 rpm with a maximum force of 1380 x G for 10 minutes. Plasma 
aliquots were stored in 2ml cryotubes at -80° C until analysis.  
 Plasma glucose concentrations were determined by the glucose oxidase method 
using a GL5 Analox Analyzer (Analox Instruments, Lunenberg, MA). Insulin 
concentrations were determined using a radioimmunoassay kit specific for human insulin 
(Linco Research Inc. St. Charles, MO). Free fatty acid and triacylglycerol concentrations 
were determined with an enzymatic colorimetric assay kit (Wako Chemicals USA Inc., 
Richmond, VA, and Sigma Chemical, St. Louis, MO, respectively). 
3.7 Plasma isotopic enrichment 
Glucose isotopic enrichment was determined using liquid chromatography-mass 
spectrometry (LCMS) according to the methods outlined by McIntosh et al. (99).  Serum 
samples (0.3 mL) were placed in 1.7-mL microcentrifuge tubes containing 1 mL of ice-
cold acetone. Samples were vortexed and incubated for 10 minutes at -20◦C; after 
chilling, samples were centrifuged for 2 min at 17,000g at 4◦C.   The supernatant was 
transferred to 12 X 75-mm borosilicate tubes (Fisher Scientific Inc., Pittsburgh, PA) and 
concentrated to dryness under ambient conditions.  Once dry, samples were reconstituted 
with 0.3 mL 75:25 acetonitrile to water, vortexed, and transferred through a 
polyethersulfone filter (4 mm, 0.45 µm) into a glass HPLC vial and capped (Fisher 
Scientific Inc., Pittsburgh, PA).  Vials were loaded into the autosampler compartment of 
the LC (Agilent 1100 series, Agilent Technologies, Santa Clara, CA) and set to an 
injection volume of 10 µL.  The LC conditions were as follows: isocratic mobile phase 
75:25 acetonitrile to water; flow rate of 1.0 mL•min-1; column temperature 35◦C.  
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Glucose eluted from the column at approximately 6 min, therefore, total run time on the 
column was set to 10 min.  After the compounds were separated using a Shodex 
Asahipak NH2P-50, 4.6 x 250 mm column (Showa Denko America, Inc., New York, 
NY), they were ionized by electrospray in the MS (Esquire 6000 (Bruker Daltronics Inc., 
Billerica, MA) and detected under the following conditions: capillary, 5500 V; endplate 
offset, 500 V; nebulizer 30.0 psi; dry gas 10.0 L•min-1;   dry temperature, 300◦C; scan 
range 100-210 m/z. 
For chromatogram analysis (Bruker Data Analysis software, Bruker Daltronics, 
Inc.), the glucose peaks were isolated, integrated, and the average mass-to-charge ratio 
was generated. Isotopic enrichment of the [6,6-2H] glucose (m/z = 205) was expressed as 
a percentage of the total glucose species (m/z = 203 + 204 + 205) as follows: 
% isotopic enrichment =   
203
203+204+205
 * 100 
3.8 Calculations 
3.8.1 Isotope-derived glucose turnover 
Glucose rate of appearance (Ra) =    //

 !" #
!

 
 
Glucose rate of disappearance (Rd) =  $	   %

      
F represents the isotopic infusion rate. IE1 and IE2 are the isotopic enrichments 
(ratio of labeled [6,6-2H] glucose to total plasma glucose) at time-points t1 and t2, 
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respectively. C1 and C2 are the concentrations of plasma glucose at t1 and t2, and V is the 
estimated volume of distribution for glucose of 180 ml/kg. 
 Whole body insulin action was defined as glucose Rd/SSPI, where SSPI is the 
mean plasma insulin concentration during the final stages of the infusion (12, 130). 
Hepatic insulin action was defined as the percent suppression of basal hepatic 
glucose production (HGP) during the glucose infusion, where greater suppression 
indicates greater hepatic insulin action =  
1 
'()*+,-.*/+
'(),0.*+1
2 100.   
HGPfasting is equal to the basal rate of appearance while HGPinfusion during the infusion is 
calculated as: 5	 5	 6785 $	  6785 958 	. 
3.8.2 Oxidative and non-oxidative glucose disposal  
 Glucose oxidative disposal was assumed to equal the carbohydrate oxidation rate 
during the continuous infusion of glucose.  Non-oxidative glucose disposal, usually 
attributed to glucose storage, was expressed as a percentage of total glucose Rd and 
calculated as:  
(:-;/.< =>/0: ;0?@/AB>?0< /C*>0*/+ ?0<
(:-;/.< =>
2 100.  
3.8.3 Metabolic flexibility   
 Whole-body substrate oxidation was estimated by calculating the respiratory 
exchange ratio (RER) in the fasted conditions and during the final 10 minutes of the 
glucose infusion using indirect calorimetry. Low RER values (i.e. 0.70-0.85) reflect a 
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greater reliance on fat oxidation where high RER values reflect greater reliance on 
carbohydrate oxidation (0.85-1.00). In subjects with “normal” insulin action, the elevated 
insulin concentrations during the infusion of glucose cause an abrupt increase in RER, 
indicative of a “switch” from primarily fat oxidation in the fasted state to primarily 
carbohydrate oxidation during the glucose infusion. The magnitude of the switch (∆ 
RER) was used as an index of metabolic flexibility. 
3.8.4 Substrate oxidation 
 Fasting and insulin-stimulated carbohydrate and fat oxidation rates were 
calculated from the VO2 and VCO2 using the formulas of Péronnet and Massicotte (117): 
     Fat oxidation rate (g/min) = 1.6946 %G2 –  1.7012 %KG2 
     Carbohydrate oxidation rate (g/min) = 4.5850 %KG2 –  3.2255 %G2 
3.9 Power and sample size analysis 
The sample size required to test for significant differences in insulin action 
between group means was calculated based on mean differences and intra-individual 
variances from a study on the acute effects of energy surplus in a similar subject 
population (52).  Since the most pertinent comparisons for this study were between 
INACTIV and INACTIV LO-CAL, the power calculations were based on a paired two-
sample t-test (alpha level 0.05) of the two-sided null hypothesis that the difference 
between these two group means was zero. Based on this calculation, testing 13 subjects 
would provide 80% power to detect a 20% difference in insulin action between these two 
conditions.  A 14th subject was included for gender balance (i.e. 7 men, 7 women). 
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3.10 Statistical analysis 
Differences in insulin action, glucose kinetics, substrate oxidation, and substrate 
and hormone variables between the three conditions were analyzed by means of linear 
mixed-effects models with planned contrast analyses using the R statistical software 
package, version 2.2.1 (R: A language and environment for statistical computing, R 
Foundation for Statistical Computing, Vienna, Austria, 2005, http://www.R-project.org).  
In addition, to determine which factor (inactivity vs. energy surplus) had a greater effect 
on insulin action we fit a model to test the separate effects of condition (inactive and 
active) and energy status (balance and surplus).  All non-normally distributed data were 
log-transformed prior to analysis. Statistical significance was accepted at p < 0.05.  
Subject characteristics are presented as mean ± standard deviation; all other data are 
expressed as mean ± standard error of the mean.  
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CHAPTER 4  
RESULTS 
4.1 Plasma glucose and insulin 
Fasting plasma glucose concentrations were not significantly different among any 
of the 3 conditions (ACTIV = 4.91 ± 0.02 mmol•L-1, INACTIV = 5.04 ± 0.03 mmol•L-1, 
INACTIV LO-CAL = 4.91 ± 0.02 mmol•L-1).  Similarly, steady-state plasma glucose 
(SSPG) during the glucose infusion (ACTIV = 9.3 ± 0.1 mmol•L-1, INACTIV = 9.4 ± 0.1 
mmol•L-1, INACTIV LO-CAL = 9.2 ± 0.1 mmol•L-1) were also not different among the 3 
conditions.  Fasting insulin concentrations were greater in both INACTIV and INACTIV 
LO-CAL (47.6 ± 1.4 pmol•L-1 and 43.7 ± 1.9 pmol•L-1, respectively) compared with 
ACTIV (39.9 ± 0.9 pmol•L-1) although these differences were not statistically significant.  
Fasting insulin concentrations also were not different between INACTIV and INACTIV 
LO-CAL. Compared to control (ACTIV), steady-state plasma insulin (SSPI) 
concentrations were  41% higher in INACTIV (p < 0.001) and 20% higher in INACTIV-
LO CAL (p=0.08) (Figure 4.1).  Insulin concentrations during the glucose infusion were 
also 18% greater in INACTIV compared to INACTIV LO-CAL (p = 0.02) (Figure 4.1).
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Figure 4.1 Steady-state plasma insulin (SSPI) concentrations during the continuous 
infusion of glucose across the 3 conditions. * p < 0.05. 
 
 
*  * 
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4.2 Glucose turnover 
 Whole-body glucose rate of disappearance (Rd) and hepatic glucose production (HGP) before (fasting) and during the glucose 
infusion are shown in Table 4.1.  During the infusion, total glucose Rd was significantly lower in INACTIV compared to both 
ACTIV (p < 0.001) and INACTIV LO-CAL (p = 0.05).  Total glucose Rd was also lower in INACTIV LO-CAL compared to ACTIV 
although this difference was not significant (p = 0.08).   
 
Table 4.1 Comparison of glucose turnover across the 3 conditions. 
 
 Glucose Rd fasting Glucose Rd infusion HGPfasting HGPinfusion 
ACTIV 21.5 ± 0.3 51.1 ± 0.6 24.0 ± 0.5 9.1 ± 0.6 
INACTIV 21.7 ± 0.8 47.4 ± 0.8
a
 22.4 ± 0.8 6.3 ± 0.5 
INACTIV LO-CAL 20.6 ± 0.5 48.7 ± 1.0
a
 21.7 ± 0.5 7.1 ± 1.0 
Note: Glucose Rd, glucose rate of disappearance; HGP, hepatic glucose production.  
Units for all variables are umol•L-1•min-1•kgFFM-1 
Data are mean and standard error. 
a
 Significantly different from ACTIV 
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4.3 Insulin action 
 
 Insulin action, as defined by Rd/SSPI, was reduced relative to ACTIV by 39% in 
INACTIV (p < 0.001) and by 18% in INACTIV LO-CAL (p = 0.07) (Fig.4.2). Rd/SSPI 
was also higher in INACTIV LO-CAL compared to INACTIV (p = 0.04).   
 Because insulin action was lower in both INACTIV and INACTIV LO-CAL 
compared to ACTIV, we further examined which factor (energy status, i.e. balance vs. 
surplus, or inactivity) was the strongest contributor to insulin action.  To do this, we fit a 
model using energy status and activity status (i.e. inactivity vs. activity) as factors.  
According to the model, only the effect of energy status was significant (p < 0.05), 
indicating that energy status has a more potent effect on insulin action compared to 
activity status.  
 To determine whether sex (male/female) or energy balance on Day -1 influenced 
the insulin action response, we performed a separate analysis incorporating these factors 
(i.e. sex, energy balance on Day -1) into the model. Unexpectedly, there was a significant 
effect of sex on insulin action, such that insulin action was higher in women compared to 
men. However, there was no sex by condition interaction suggesting the response to the 
intervention was the same regardless of sex.  There was no significant effect of energy 
balance on Day -1 on insulin action (p > 0.05).  Therefore, differences in insulin action 
between conditions cannot be explained by energy balance on Day -1. 
 The energy content and composition of the evening meal on Day 1 was the same 
for each subject across all 3 conditions (i.e. 1030 kcal). Therefore, the percent 
contribution of the evening meal to total daily energy intake (% contribution) varied 
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between subjects (i.e. higher % contribution in subjects with low total daily energy intake 
and vice versa) and between condition (i.e. higher % contribution in INACTIV LO-CAL 
compared to ACTIV and INACTIV).  To assess whether % contribution of the evening 
meal had a significant impact on insulin action, we included % contribution of the 
evening meal into the model formula.  There was no significant effect of % contribution 
of the evening meal on Rd/SSPI, nor did its inclusion in the model affect model outcomes. 
Figure 4.2 Insulin action (Rd/SSPI) assessed during the continuous infusion of glucose 
across the 3 conditions. SSPI, steady-state mean of 50, 55, and 60 min plasma insulin 
concentrations. * p < 0.05. 
 
 
4.4 Partitioning of insulin-mediated glucose disposal 
Non-oxidative glucose disposal, expressed as a percentage of total glucose Rd, 
was higher and percent oxidative disposal was lower in INACTIV LO-CAL compared to 
INACTIV (p < 0.05) (Figure 4.3). Non-oxidative glucose disposal was greater (61± 2.0% 
vs. 54 ± 1.3%) and oxidative disposal was lower (39 ± 2.0% vs. 46% ± 1.3) in INACTIV 
 * * 
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LO-CAL compared to ACTIV, respectively, although these differences were not 
significant (p > 0.05). There were no differences in non-oxidative or oxidative glucose 
disposal between ACTIV and INACTIV (p > 0.05).  
Figure 4.3 Partitioning of insulin-mediated glucose disposal (Rdinfusion) across the 3 
conditions.  The open (white) portion of the column reflects non-oxidative disposal and 
the gray portion reflects CHO oxidation.  *, p < 0.05 when compared with INACTIV. 
 
 Basal glucose Ra (HGPfasting) and hepatic glucose production during the infusion 
(HGPinfusion) were similar between the 3 conditions (Table 4.1).  In all 3 conditions, the 
glucose infusion partially suppressed HGP, with residual HGP lowered to 27-38% of 
fasting values. Hepatic insulin action, defined as percent suppression of HGPfasting during 
the infusion, was not significantly different between the 3 conditions (Figure 4.4). 
* 
* 
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Figure 4.4 Hepatic insulin action (percent suppression of fasting hepatic glucose 
production during the glucose infusion) across the 3 conditions. 
 
4.5 Markers of lipid metabolism 
Fasting triacylglycerol (TAG) concentrations on Day 1 were similar across the 3 
conditions (p > 0.05) (Figure 4.5). Fasting TAG concentrations on Day 2 (i.e. prior to the 
continuous infusion of glucose) were 27% lower in the active condition (ACTIV) 
compared to INACTIV (p < 0.01) (Figure 4.5).  TAG levels were also 20% lower in 
INACTIV LO-CAL compared to ACTIV, although this difference was not significant (p 
> 0.05).  There were no differences in fasting TAG concentrations on Day 2 between 
INACTIV and INACTIV LO-CAL (p > 0.05).  To further examine whether there was an 
effect of intervention on fasting TAG concentrations, we examined the change in fasting 
TAG from Day1 to Day 2 (i.e. ∆ TAGfasting (Day 2 – Day 1) (Figure 4.6). The change to 
fasting TAG levels were much smaller in INACTIV (+3%, p < 0.01) and INACTIV LO-
CAL (-6%, p = 0.10) compared to ACTIV (-20%) (Figure 4.6). During the continuous 
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infusion of glucose, TAG concentrations were not different between conditions (p > 0.05) 
(Table 4.5).   
Fasting and insulin-stimulated plasma free fatty acid (FFA) concentrations were 
similar among the 3 conditions.  There were also no differences in fasting or insulin-
stimulated lipid oxidation (LIPIDox (mg•min-1)) between conditions, although LIPIDox 
during the glucose infusion was slightly greater in INACTIV LO-CAL compared to 
INACTIV (p = 0.08) (Table 4.2). Similarly, respiratory exchange ratios (RER) were 
similar across conditions in the fasted state (Figure 4.7).  However, during the glucose 
infusion, RER values were significantly higher in ACTIV (p = 0.05) and INACTIV (p = 
0.02), indicating greater reliance on carbohydrate oxidation compared to INACTIV LO-
CAL (Figure 4.7). 
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Table 4.2 Markers of lipid metabolism across the 3 conditions. 
Note: ∆, % Change (Infusion – Fasting); LIPIDox, rate of lipid oxidation; FFA, free fatty acid; TAG, triacylglycerol.  Data are mean 
and standard error. 
a
, Significantly different from ACTIV
 
LIPIDoxfasting 
(mg•min-1) 
LIPIDoxinfusion 
(mg•min-1) 
∆ LIPIDox 
% 
FFAfasting 
(mmol•L-1) 
FFAinfusion 
(mmol•L-1) 
∆FFA      
% 
TAGfasting 
(mg•dL-1) 
TAGinfusion 
(mg•dL-1) 
ACTIV 95.6 ± 3.1 60.8 ± 2.9 -39.9 ± 2.3 0.27  ± 0.01 0.08 ± 0.00 -68.4 ± 1.2 62.3 ± 2.2 62.8 ± 2.3 
INACTIV 86.4 ± 3.3 57.8 ± 2.4 -33.7 ± 2.5 0.24 ± 0.01 0.07 ± 0.00 -68.6 ± 1.3 79.2 ± 2.9a 72.3 ± 2.9 
INACTIV  
LO-CAL 
98.9 ± 2.9 71.0 ± 2.9 -31.2 ± 2.2 0.31 ± 0.01 0.08 ± 0.00 -73.9 ± 1.1 74.8 ± 4.3 68.8 ± 3.3 
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Figure 4.5 Fasting TAG concentrations on Day 1 (in gray) and Day 2 (in black) across 
the 3 conditions. * p < 0.05 when compared with ACTIV. 
 
 
Figure 4.6 Change in fasting TAG concentrations from Day 1 to Day 2 across the 3 
conditions.* p < 0.05 when compared with ACTIV. 
 
* 
  * 
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 To examine whether there were differences in the suppression of FFAs and 
LIPIDox by the elevated circulating insulin concentrations during the infusion, we 
compared the change in FFA from the fasted to insulin-stimulated state (∆FFA) as well as 
the percent change in lipid oxidation rates (∆LIPIDox) in all 3 conditions (Table 4.2).  
There were no significant differences in either variable (∆FFA and ∆LIPIDox) between 
conditions. We also compared the change in the respiratory exchange ratio from the 
fasted to insulin-stimulated state (∆RER) to examine differences in metabolic flexibility 
between conditions.  Although there was a more dynamic increase in RER, as indicated 
by a steeper slope of the line in Figure 4.7., in ACTIV compared to INACTIV and 
INACTIV LO-CAL, there were no significant differences in ∆RER between conditions. 
Figure 4.7 Respiratory exchange ratio (RER) across the 3 conditions.  *, p ≤ 0.05 when 
compared with INACTIV LO-CAL. 
 
 * 
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CHAPTER 5  
DISCUSSION 
 
 The purpose of this study was to determine the metabolic response to one day of 
inactivity (prolonged sitting), with and without the potential confounding effect of energy 
surplus, in healthy, young adults.  To test the specific aims, we compared the metabolic 
response to 24 hours of: 1) high non-exercise activity with energy intake = energy 
expenditure (ACTIV); 2) inactivity (sitting) with energy intake > expenditure, i.e. energy 
surplus (INACTIV); and 3) inactivity with energy intake = expenditure (INACTIV LO-
CAL).  The main findings of the study were: 1) compared to the active condition, 24-
hours of inactivity, with no change to diet, significantly reduced insulin action; and 2) 
reducing energy intake to match low energy expenditure during inactivity (INACTIV 
LO-CAL) significantly attenuates, but does not completely prevent, the deleterious effect 
of inactivity on insulin action. Thus, mechanisms other than energy surplus are also 
involved in the inactivity-induced decline in insulin action.  
  Several studies in animals and humans have reported clear, deleterious 
consequences of inactivity on metabolic processes including insulin action (8, 14, 90, 
100, 114, 119, 131, 137). The time course of metabolic changes is not clear from these 
studies due to different inactivity protocol durations. For example, studies in rodents 
report significant declines in insulin-stimulated glucose uptake in as little as 24-48 hours 
following hindlimb immobilization (119, 131). In humans, the earliest detectable 
reduction in insulin action has been observed following 3 days of bed rest (90, 133). 
Notably, the present study is the first to document considerable reductions in whole-body 
insulin action following just one day of inactivity in humans.  Further, the magnitude of 
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the reduction in insulin action in such a short period of time is remarkable considering the 
similar declines (~30%) reported after longer periods (i.e. days - weeks) of inactivity (90, 
100, 133). Therefore, reduced insulin action in humans appears to be a very early 
metabolic maladaptation to inactivity that is sustained over the course of at least several 
weeks of continued inactivity.  
5.1 Metabolic response to inactivity versus exercise 
Previous data on the regulation of lipoprotein lipase (LPL) activity suggest that 
the underlying mechanism(s) and the magnitude of the metabolic response to inactivity 
are not simply the opposite of the response to exercise (54). In the present study, the 
decline in insulin action in response to inactivity (~18-39%) was similar in magnitude to 
the increase in post-exercise insulin action observed in other studies (i.e. ~15-44%) (7, 
67, 134).  Thus, in contrast to LPL activity, it seems that the insulin action response to 
inactivity closely mirrors the response to exercise, although the mechanisms underlying 
those responses may be distinctly different. However, without direct comparisons 
between the metabolic effects of exercise and inactivity on insulin action in the same 
subject population, we cannot determine whether the magnitude of change in insulin 
action is different in response to similar increases and decreases in energy expenditure. 
 Another novel aspect of the current study is the inactivity paradigm used. 
Whereas previous studies in humans have mainly utilized bed rest as a model for 
inactivity, we used a prolonged sitting protocol to experimentally reduce standing and 
ambulation. Therefore, results from the present study are more relevant to the general 
population who spend considerable portions of the waking day engaged in sedentary 
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behaviors involving sitting (97). Recent epidemiological data suggest a positive 
relationship between time spent in sedentary behaviors and risk for insulin resistance and 
type 2 diabetes (35, 59, 60, 70).  Results of this study provide additional evidence for a 
strong, cause-and-effect relationship between sedentary behavior associated with sitting 
and metabolic health outcomes reported in the epidemiological literature. 
5.2 Mechanisms underlying inactivity-induced changes to insulin action 
The mechanisms involved in the rapid, inactivity-induced decline in insulin action 
are not well-characterized.  Potential factors that could account for lower insulin action 
following inactivity could involve reduced glucose transport, glucose oxidation and/or 
storage (i.e. non-oxidative glucose disposal). Defects in insulin-stimulated glucose 
disposal are often attributable to impaired non-oxidative glucose metabolism (16, 23, 
118). Accordingly, several studies have reported selective impairments in glycogen 
synthesis and insulin-mediated non-oxidative glucose disposal following inactivity (100, 
131). However, compared to the active condition, non-oxidative glucose disposal did not 
change following inactivity, suggesting that reduced insulin action in either of the 
inactive conditions is not attributable to impaired glucose storage. Several studies have 
reported a significant reduction in glucose transporters (GLUT-4) following inactivity 
(138, 145), which has been directly related to the inactivity-induced decline in insulin 
action (145). Although not measured in the present study, changes to glucose transport 
capacity may therefore be a more plausible mechanism for the inactivity-induced decline 
in insulin action. Other potential mechanisms are greater circulating levels of 
counterregulatory hormones (e.g. glucagon, epinephrine, cortisol) (144), decreased 
muscle blood flow (100), or increased systemic inflammation (11, 18). The data are 
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inconsistent, however, as to whether any of these factors play a major role in the insulin 
action response to inactivity. In summary, the diversity of findings suggests that the 
mechanism to explain the reduction in insulin action in response to inactivity is 
multifactorial and complex, but likely involves impaired glucose transport capacity.  
5.3 Role of energy surplus on the insulin action response to inactivity 
Considering the important effects of diet adds complexity to understanding the 
effects of inactivity on insulin action. Data from Stettler et al. (135) highlighted the 
importance of diet composition on whole-body insulin action following inactivity. In that 
study, the inactivity-induced decline in insulin action was prevented when the proportion 
of dietary fat was reduced from 45% to 15% of total calories. Results of the present study 
expand upon prior research by emphasizing the importance of a previously unexplored 
mechanism (i.e. energy surplus) on the metabolic response to inactivity. Holding 
macronutrient composition constant, energy surplus accounted for 53% of the deleterious 
effects of inactivity on insulin action. Taken together, these results suggest that energy 
surplus plays a key role in the metabolic response to inactivity, although diet composition 
may be important.   
It is clear from studies in both animals (146) and humans (4, 52, 113) that energy 
surplus elicits decrements in insulin action prior to significant changes in body weight. In 
a previous study in our laboratory, insulin action was 30% lower after to 3 days of 
overfeeding (i.e. energy surplus) (52) in active men and women. The independent effects 
of energy surplus could not be determined since the 3-day overfeeding period was 
coupled with a reduction in structured exercise (52).  To our knowledge, the present study 
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is the first to document the independent effect of energy surplus on insulin action when 
activity/energy expenditure is carefully controlled.    
  Further, results from this study provide insight into the duration of the metabolic 
response to energy surplus.  No studies have examined the effects of energy surplus 
lasting less than ~2 days; thus, it is unclear whether changes to insulin action occur in 
response to acute (i.e. effect of the last meal) or more chronic changes to energy balance 
(i.e. days).  The study design used in the present study provides insight into this 
uncertainty. To eliminate energy surplus during inactivity, we reduced the caloric content 
of breakfast and lunch. However, we standardized the energy content of the evening meal 
(i.e. 1030 kcals), temporarily restoring acute energy balance between conditions, which 
may have minimized differences in insulin action. Remarkably, despite the equivalent 
energy content of the evening meal, there were clear differences in insulin action between 
the two inactive conditions. Therefore, the metabolic effect of a surplus of calories at 
breakfast and lunch was sustained. While it is possible that a surplus of calories in the 
evening meal could have augmented differences between the inactive conditions, these 
results suggest that the metabolic response to energy surplus persists over the course of at 
least one day (i.e. 24 hours).  
When considering the separate effects of activity and energy status on insulin 
action, only the effect of energy status was statistically significant.  This result suggests 
that energy status, rather than activity, has a stronger independent influence on whole-
body insulin action. However, although not statistically significant, the effect of inactivity 
per se is clearly physiologically relevant because inactivity independently accounted for 
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47% of the decline in insulin action.  Thus, it is presumptuous to conclude from these 
results that energy status is more important than activity when both are clearly relevant.   
5.4 Potential mechanisms involved in the metabolic response to inactivity and 
insulin action 
 There are several potential mechanisms to explain lower insulin action in the 
inactive, energy surplus condition.  Non-oxidative glucose disposal was significantly 
lower following inactivity with no change to diet compared to inactivity with reduced 
energy intake. This observation provides evidence for impaired glucose storage as a 
mechanism to explain the energy surplus-mediated reduction in insulin action. Although 
not measured, differences in non-oxidative glucose disposal between the two inactive 
conditions could be explained by differences in muscle glycogen stores.  Although net 
glycogen breakdown is negligible under conditions when demand for ATP is low (e.g. 
during inactivity) (23), significantly greater carbohydrate intake in INACTIV compared 
to INACTIV LO-CAL (426 g CHO vs. 280 g CHO) may have led to moderate, but 
important increases in muscle glycogen content in INACTIV. Elevated muscle glycogen 
levels would be expected to reduce insulin activation of glycogen synthase (15, 87, 94) 
providing a potential mechanism to explain the lower insulin-mediated glucose disposal 
following inactivity with no change to diet compared to inactivity with reduced energy 
intake. However, without direct measurements of muscle glycogen and/or glycogen 
synthase activity, we are unable to determine the mechanistic relationship between these 
factors and our results. 
 Impaired insulin signaling to glucose transport could also account for lower 
insulin-mediated glucose uptake following inactivity with no change to diet compared to 
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inactivity with reduced intake. Data from previous studies indicate that nutrient 
oversupply of glucose and/or fatty acids impairs key components of the insulin signaling 
pathway (50, 73, 81, 85, 88, 111, 115), potentially via upregulation of the hexosamine 
biosynthetic pathway (111, 115); upregulation of inflammatory pathways (11, 49, 55) 
and/or via accumulation of intracellular fatty acid moieties (81). In sum, multiple and 
complex mechanisms are likely responsible for the significantly greater reduction in 
insulin action following inactivity without change to energy intake.   
5.5 Hepatic insulin action 
 Hepatic insulin action, as assessed by percent suppression of fasting hepatic 
glucose production (HGP) by the glucose infusion, was not significantly different 
between conditions.  These results are consistent with studies showing that 7 days of bed 
rest did not change hepatic insulin action in men (14, 100, 137).  In contrast, Blanc et al. 
(14) reported significant reductions in suppression of fasting hepatic glucose production 
after 7 days of bed rest in women, suggesting a potential sex difference in the response to 
inactivity. In the present study, although the pattern of the hepatic insulin action response 
to inactivity was different in women versus men (23% increase vs. 5% increase, 
respectively), these differences were not statistically significant. Although we may have 
lacked sufficient power to detect differences, the existence of sex differences in hepatic 
insulin action following inactivity in men versus women is dubious. Therefore, additional 
research is warranted to determine whether there are distinct gender differences in the 
response to inactivity and the mechanism to explain these differences.   
 The direction of the hepatic insulin action response was opposite to what we 
anticipated. Numerically, hepatic insulin action was lowest in the active condition, 
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highest following inactivity with no change to diet, and was intermediate following 
inactivity with reduced energy intake. However, since glucose Ra and Rd are not 
independent, less suppression of HGP (greater glucose production) in the active condition 
could be explained by the higher glucose Rd. Nonetheless, our results support the general 
finding that inactivity (lasting ≤ 7 days) has a negligible impact on hepatic insulin action, 
in stark contrast to the large reduction to whole-body insulin action. 
5.6 Metabolic flexibility and lipid metabolism 
 In addition to deleterious effects of inactivity on insulin action, several studies 
also report detrimental effects of inactivity on lipid metabolism (8, 10, 155). For instance, 
in rodents there are striking increases in postprandial TAG concentrations within 4-12 
hours of hindlimb unloading. These changes are attributable to large (i.e. ≥ 50%) 
reductions in lipoprotein lipase (LPL) activity (10, 53). In contrast to those previous 
studies, we did not observe changes to lipid metabolism (i.e. insulin-mediated 
suppression of lipolysis (∆ FFA), suppression of lipid oxidation (∆ LIPIDox)), after 
inactivity with or without energy surplus. These results suggest these aspects of lipid 
metabolism are relatively unaffected by 1 day of prolonged sitting. However, compared 
to the active condition, fasting TAG concentrations 24 hours after the intervention were 
greater in both inactive conditions (+27% INACTIV; +20% INACTIV LO-CAL), 
although the difference was only statistically significant in the condition when diet was 
not changed.  In addition, the change in fasting TAG concentrations after the intervention 
(i.e. O	 2  O	 1) was negligible in the inactive condition (+3 mg/dL, p=0.02) and in 
the inactive, reduced energy intake condition (-4 mg/dL, p>0.05) compared to the active 
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condition (-14 mg/dL). Bey et al. (10) also reported that fasting TAG concentrations did 
not change after 12-18 hours of hindlimb unloading in rodents. Thus, these results 
suggest that short-term (i.e. ≤ 24 hours) inactivity has little effect on fasting TAG 
compared to the dramatic changes to postprandial TAG levels reported by Bey et al. (10). 
 Insulin resistance is often associated with metabolic inflexibility (i.e. impaired 
“switching” from primarily lipid oxidation to primarily carbohydrate oxidation in 
response to insulin stimulation (77)). Therefore, we hypothesized that the shift in the 
respiratory exchange ratio (RER) from the fasting to insulin-stimulated state (∆RER) 
would be blunted after 24 hours of inactivity.  Despite a 22% lower ∆RER in both 
inactive conditions compared to ACTIV, indicative of lower metabolic flexibility, these 
differences were not statistically significant. Overall, these data suggest that 24 hours of 
inactivity has more subtle effects on lipid metabolism (with the exception of the 
postprandial lipid response) and metabolic flexibility compared with the larger changes to 
whole-body insulin action. 
 In contrast, other studies employing longer-term inactivity protocols (i.e. days, 
weeks) report significant decrements in markers of lipid metabolism (8, 14).  For 
example, Bergouignan et al. (8) reported a 37% increase in fasting TAG levels and an 8% 
decrease in palmitate oxidation following one month of bed rest in healthy women. Blanc 
et al. (14) reported even more dramatic reductions in fasting lipid oxidation (i.e. ~90%) in 
response to a shorter period of bed rest (i.e. 7 days) in healthy women and men (14). 
Thus, the majority of the detrimental effects of inactivity on lipid metabolism, metabolic 
flexibility, and insulin-mediated suppression of lipolysis may take at least one week or 
longer to manifest compared to the rapid effects of inactivity on insulin action. 
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5.7 Importance of non-exercise activity on metabolic health 
 Epidemiological evidence to date indicates the importance of low-intensity, non-
exercise activities associated with daily living (e.g. standing, ambulating, household 
chores, etc.) on metabolic health (59, 61, 70).  An important finding of the present study 
was the 20% reduction in fasting TAG levels in response to one day of high, non-exercise 
activity. The magnitude of this change is similar to the ~30% reduction in fasting TAG 
commonly reported following prolonged (i.e. ≥ 2 hours) of moderate exercise (27, 39, 47, 
140).  Interestingly, exercise duration appears to have a more potent effect on fasting 
plasma TAG levels than exercise intensity when total energy expenditure is held constant 
(24, 25, 80, 143). Data from the present study suggest that a sufficient quantity of low-
intensity (i.e. < 4 METs) activities of daily living appears to lower fasting TAG as 
effectively as a prolonged bout of moderate exercise. To our knowledge, this is the first 
experimental study to provide direct evidence for a beneficial effect of high, non-exercise 
activity on metabolic health.   
Thus, data from the current study extend the findings from cross-sectional studies that the 
health benefits of high daily energy expenditure on health can be gained via increases in 
non-exercise activity.   
5.8 Limitations and control for confounding variables 
The use of healthy, normal-weight, active subjects may limit the generalizability 
of the study results to the general population.  We chose to study the metabolic response 
to inactivity in recreationally-active, but not highly-trained, individuals to eliminate a 
potential confounding impact of detraining on these responses. This population was also 
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selected in order to minimize potential confounding effects of disease processes often 
observed in overweight individuals who have low levels of physical activity.   
Another limitation of the study is the short-term (24-hour) period of inactivity 
since short-term metabolic adaptations to inactivity with concurrent energy surplus may 
not be reflective of longer term changes to insulin action. Lack of significant changes to 
lipid metabolism in response to 24 hours of inactivity certainly suggests this is true.  
However, the decline in insulin action was similar in magnitude compared to other 
studies that were longer in duration (90, 100, 133, 137). Further, compared to longer-term 
studies, examining these responses over 24 hours was advantageous because it allowed 
for greater control over study conditions and eliminated potential confounding factors 
such as muscle atrophy and/or changes in body composition.  
Energy balance and/or the amount of physical activity performed on the days 
leading up to each 24-hour intervention may have influenced the response to inactivity. 
To control energy balance, subjects were given all food to eat each day prior to the 
intervention (i.e. Day -1). Based on estimated energy intake and expenditure, we 
calculated energy balance for Day -1, which did not differ between conditions (p > 0.05). 
Therefore, we are confident that energy balance on Day -1 did not impact the metabolic 
response to the 24-hour protocol.  To eliminate the potential confounding influence of 
prior exercise, subjects were asked to refrain from structured exercise for 2 days prior to 
each intervention. Based on activPal data, energy expenditure as well as total sitting, 
standing, and stepping time on Day -1 were not different between conditions. Therefore, 
prior physical activity had negligible impact on the response to inactivity.  
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Finally, given the large differences in energy intake (~-1000 kcal/d) and similar 
activPal data (i.e. total sitting and standing time) between the two inactive conditions we 
are confident that, as designed, these two groups were in different energy states. It is 
possible we may have underestimated energy expenditure in the active condition. Data 
from Crouter et al. (26) indicate the metabolic equivalent of standing is less than what the 
activPal software assumes (i.e. 1.19 vs. 2.0 MET/hr, respectively). If actual energy 
expenditure was lower than estimated, differences in insulin action between the active 
and inactive conditions would likely be minimized. However, the fact that we observed 
such a large reduction in insulin action in the inactive versus active condition suggests 
that our estimates approximated true energy expenditure. It is possible though that the 
difference between energy intake and expenditure (i.e. energy balance) in the active 
condition may have been larger than estimated (i.e. +162 ± 248 kcal/d), which could have 
impacted our ability to detect significant differences in insulin action between this 
condition and the inactive condition with reduced energy intake. If anything, the effect of 
inactivity may be even larger than what we observed.  
5.9 Summary and practical implications 
   In summary, results of this study are consistent with data from both animal (119, 
131) and human (8, 14, 91, 100, 133) studies indicating the clear, deleterious effects of 
inactivity on insulin action.  However, our results extend these findings by implicating 
the important role for energy surplus in the inactivity-induced decline in insulin action.  
Thus, the detrimental effects of inactivity on insulin action can be minimized if energy 
intake is reduced to match energy expenditure during inactivity.  Still, 47% of the decline 
in insulin action was not attributable to energy surplus suggesting that other mechanisms 
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are involved in the process. Additional research is necessary to determine the cellular and 
molecular mechanisms mediating the direct effect of inactivity on metabolism.  Future 
studies examining the mechanism for the reduction in insulin action following inactivity 
should carefully control energy balance.   
  The dramatic reduction in insulin action within just one day of prolonged sitting 
suggests the importance of maintaining daily non-exercise activity to minimize 
detriments to metabolic health. In this regard, it may be prudent to develop public health 
strategies aimed at limiting sitting and increasing daily non-exercise activity.  Since 
adults spend the majority of waking hours (i.e. > 90%) engaged in sedentary behaviors or 
light-intensity activities (61), decreasing time spent sitting and/or increasing non-exercise 
activities could substantially raise total daily energy expenditure and lead to improved 
metabolic health (33, 54, 89, 97, 148).
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APPENDIX A 
SCHEDULE OF ACTIVITIES DURING THE ACTIVE CONDITION 
 
Arrival in 
lab:  
 
8 - 9 AM 
  
 
Min     MET value 
 0:00-5:00 Sit and eat 1.3 
 5:00-10:00 Sit and eat 1.3 
Hour 10:00-15:00 Sit and eat 1.3 
Hour 1 15:00-20:00 Stand and eat 2 
 20:00-25:00 tidy up room 2.5 
 25:00-30:00 Dishes 1.8 
~8:00 AM 30:00-35:00 sweep 3 
 35:00-40:00 fold laundry 2.3 
 40:00-45:00 walk to parking lot 3.8 
 45:00-50:00 walk 3.8 
 50:00-55:00 board games/cards 2 
 55:00-60:00 board games/cards 2 
    
  Avg. 2.26 
 9-10 AM   
 0:00-5:00 work @ computer 2 
 5:00-10:00 work @ computer 2 
 10:00-15:00 work @ computer 2 
Hour 2 15:00-20:00 work @ computer 2 
~9:00 AM 20:00-25:00 vacuuming 3.5 
 25:00-30:00 vacuuming 3.5 
 30:00-35:00 board games/cards 2 
 35:00-40:00 board games/cards 2 
 40:00-45:00 board games/cards 2 
 45:00-50:00 Sit 1.3 
 50:00-55:00 Sit 1.3 
 55:00-60:00 Sit 1.3 
    
  Avg. 2.08 
 10-11 AM   
 0:00-5:00 work @ computer 2 
 5:00-10:00 work @ computer 2 
Hour 3 10:00-15:00 work @ computer 2 
~10:00 AM 15:00-20:00 work @ computer 2 
 20:00-25:00 work @ computer 2 
 25:00-30:00 sweep 3 
 30:00-35:00 sweep 3 
 35:00-40:00 take out trash 3 
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 40:00-45:00 tidy up room 3 
 45:00-50:00 Sit 1.3 
 50:00-55:00 Sit 1.3 
 55:00-60:00 Sit 1.3 
    
  Avg. 2.16 
 11 AM - 12 PM   
 0:00-5:00 Sit 1.3 
 5:00-10:00 Sit 1.3 
 0:00 - 15:00 Sit 1.3 
 15:00-20:00 Stand 2 
 20:00-25:00 Stand 2 
Hour 4 25:00-30:00 stand 2 
~11:00 AM 30:00-35:00 stand 2 
 35:00-40:00 stand 2 
 40:00-45:00 dust 2.4 
 45:00-50:00 dust 2.4 
 50:00-55:00 vacuuming 3.5 
 55:00-60:00 vacuuming 3.5 
    
   2.14 
 12 PM - 1 PM   
 0:00-5:00 tidy up room 3 
 5:00-10:00 sit and eat 1.3 
 10:00-15:00 sit and eat 1.3 
Hour 5 15:00-20:00 sit and eat 1.3 
~12:00 PM 20:00-25:00 sit and eat 1.3 
 25:00-30:00 sit and eat 1.3 
 30:00-35:00 sit and eat 1.3 
 35:00-40:00 stand and eat 2 
 40:00-45:00 fold laundry  2.3 
 45:00-50:00 fold laundry  2.3 
 50:00-55:00 sweep 3 
 55:00-60:00 sweep 3 
    
   1.95 
 1-2 PM   
 0:00-5:00 work @ computer 2 
 5:00-10:00 work @ computer 2 
 10:00-15:00 work @ computer 2 
Hour 6 15:00-20:00 work @ computer 2 
~1:00 PM 20:00-25:00 work @ computer 2 
 25:00-30:00 work @ computer 2 
 30:00-35:00 work @ computer 2 
 35:00-40:00 vacuum 3.5 
 40:00-45:00 vacuum 3.5 
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 45:00-50:00 put away groceries 2.5 
 50:00-55:00 put away groceries 2.5 
 55:00-60:00 sweep 3 
    
   2.42 
 2-3 PM   
 0:00-5:00 sweep 3 
 5:00-10:00 tidy up room 2.5 
 10:00-15:00 tidy up room 2.5 
Hour 7 15:00-20:00 work @ computer 2 
~ 2:00 PM 20:00-25:00 work @ computer 2 
 25:00-30:00 darts 2.5 
 30:00-35:00 darts 2.5 
 35:00-40:00 darts 2.5 
 40:00-45:00 darts 2.5 
 45:00-50:00 darts 2.5 
 50:00-55:00 darts 2.5 
 55:00-60:00 darts 2.5 
    
   2.46 
 3-4 PM   
 0:00-5:00 stand 2 
 5:00-10:00 stand 2 
 10:00-15:00 vacuum 3.5 
Hour 8 15:00-20:00 vacuum 3.5 
~ 3:00 PM 20:00-25:00 darts 2 
 25:00-30:00 darts 2 
 30:00-35:00 darts 2 
 35:00-40:00 darts 2 
 40:00-45:00 darts 2 
 45:00-50:00 darts 2 
 50:00-55:00 darts 2 
 55:00-60:00 darts 2 
    
   2.25 
 4-5 PM   
 0:00-5:00 darts 2.5 
 5:00-10:00 darts 2.5 
 10:00-20:00 darts 2.5 
Hour 9 20:00-25:00 darts 2.5 
 25:00-30:00 darts 2.5 
~4:00 PM 30:00-35:00 darts 2.5 
 35:00-40:00 darts 2.5 
 40:00-45:00 darts 2.5 
 45:00-50:00 darts 2.5 
 50:00-55:00 Sit/catheter insertion 1.3 
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 55:00-60:00 Sit 1.3 
    
   2.28 
 5-6 PM   
 0:00-5:00 sit and eat 1.3 
 5:00-10:00 sit and eat 1.3 
 10:00-15:00 sit and eat 1.3 
 15:00-20:00 sit and eat 1.3 
 20:00-25:00 stand and eat 2 
Hour 10 25:00-30:00 stand and eat 2 
~5:00 PM 30:00-35:00 work at computer 2 
 35:00-40:00 work at computer 2 
 40:00-45:00 work at computer 2 
 45:00-50:00 work at computer 2 
 50:00-55:00 work at computer 2 
 55:00-60:00 work at computer 2 
    
   1.77 
 6-7 PM   
 0:00-5:00 play games 2 
 5:00-10:00 play games 2 
 10:00-15:00 play games 2 
Hour 11 15:00-20:00 play games 2 
~6:00 PM 20:00-25:00 play games 2 
 25:00-30:00 play games 2 
 30:00-35:00 play games 2 
 35:00-40:00 play games 2 
 40:00-45:00 play games 2 
 45:00-50:00 walk 3.8 
 50:00-55:00 walk 3.8 
 55:00-60:00 Sit 1.3 
    
   2.24 
 7-8 PM   
 0:00-5:00 Sit 1.3 
 5:00-10:00 play games 2 
 10:00-15:00 play games 2 
Hour 12 15:00-20:00 play games  2 
~7:00 PM 20:00-25:00 play games 2 
 25:00-30:00 play games 2 
 30:00-35:00 play games 2 
 35:00-40:00 play games 2 
 40:00-45:00 play games 2 
 45:00-50:00 play games 2 
 50:00-55:00 Sit 1.3 
 55:00-60:00 Sit 1.3 
 72 
    
   1.83 
 8-9 PM   
 0:00-5:00 walk outside 3.8 
 5:00-10:00 stand outside 2 
 10:00-15:00 stand outside 2 
Hour 13 15:00-20:00 walk inside 3.8 
~8:00 PM 20:00-25:00 work on computer 2 
 25:00-30:00 work on computer 2 
 30:00-35:00 work on computer 2 
 35:00-40:00 work on computer 2 
 40:00-45:00 work on computer 2 
 45:00-50:00 Sit 1.3 
 50:00-55:00 Sit 1.3 
 55:00-60:00 Sit 1.3 
    
   2.13 
 9-10 PM   
 0:00-5:00 Sit 1.3 
 5:00-10:00 Sit 1.3 
 10:00-15:00 Sit 1.3 
Hour 14 15:00-20:00 play games 2 
~9:00 PM 20:00-25:00 play games 2 
 25:00-30:00 play games 2 
 30:00-35:00 play games 2 
 35:00-40:00 play games 2 
 40:00-45:00 play games 2 
 45:00-50:00 play games 2 
 50:00-55:00 play games 2 
 55:00-60:00 play games 2 
    
   1.83 
 10-11 PM   
 0:00-5:00 sit  1.3 
 5:00-10:00 sit  1.3 
 10:00-15:00 sit  1.3 
Hour 15 15:00-20:00 walk to bathroom 3.8 
~10:00 PM 20:00-25:00 self care 2 
 25:00-30:00 self care 2 
 30:00-35:00 walk to lab 3.8 
 35:00-40:00 stand 2 
 40:00-45:00 stand 2 
 45:00-50:00 sit  1.3 
 50:00-55:00 sit  1.3 
 55:00-60:00 sit  1.3 
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   1.95 
 11-12 PM   
 0:00-5:00 play games 2 
 5:00-10:00 play games 2 
 10:00-15:00 play games 2 
Hour 16 15:00-20:00 play games 2 
~11:00 PM 20:00-25:00 Sit 1.3 
 25:00-30:00 Sit 1.3 
 30:00-35:00 Sit 1.3 
 35:00-40:00 Sit 1.3 
 40:00-45:00 Sit 1.3 
 45:00-50:00 Sit 1.3 
 50:00-55:00 Sit 1.3 
 55:00-60:00 Sit 1.3 
    
   1.53 
    
 
 
 
 
 
 
 
 
 
 
Total AVG  2.08 
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APPENDIX B  
TABLES AND FIGURES 
Table A.1 Energy balance and activPal data for Day -1 (M ± SD). 
 
Sitting 
Time (hrs) 
Standing 
Time (hrs) 
Stepping 
Time (hrs) 
Sleep Time 
(hrs) 
Energy 
Expenditure 
(kcals/day) 
Energy 
Intake 
(kcals/day) 
Energy 
Balance  
(EI-EE) 
 
ACTIV 
 
10.1 ± 2.1 
 
3.8 ± 1.9 
 
1.5 ± 1.0 
 
8.3 ± 1.9 
 
2497 ± 438 
 
2420 ± 478 
 
-77 ± 277 
INACTIV 9.6 ± 2.5 3.7 ± 1.6 1.5 ± 0.5 9.1 ± 2.0 2311 ± 456 2157 ± 455 -87 ± 164 
INACTIV LO-CAL 10.7 ± 2.2 3.1 ± 1.6 1.6 ± 0.8 8.6 ± 1.1 2430 ± 450 2338 ± 493 -92 ± 145 
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Figure A.1 Relationship between energy balance on Day -1 and insulin action measured 
24 hours following the intervention. 
 
  
Figure A.2 Relationship between energy balance during the 24-hour intervention (Day 1) 
and insulin action measured the following morning. 
r
2
 = 0.05 
r
2
 = 0.09 
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Figure A.3 Relationship between energy content of the evening meal (% total daily 
energy intake) during the 24-hour intervention (Day 1) and insulin action measured the 
following morning. 
 
 
 
r
2
 = 0.08 
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Figure A.4 Insulin action (Rd/SSPI) across condition in men (a) and women (b). 
a. 
 
 
b.  
 
 
 
 
 
 78 
Figure A.5 Hepatic insulin action (% suppression fasting hepatic glucose production) in 
men (a) and women (b). 
a. 
 
 
b. 
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